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Acknowledgments, by prior agreement between the student and the Graduate Thesis
Committee.
5. It is the student’s responsibility to secure copyright permissions when necessary (e.g.,
permission from a journal to use a published paper in the thesis or dissertation).
6. Programs may choose to develop program-wide guidelines on the use of publications
in theses or dissertation.
10.2

Approvals Related to Thesis

10.2.1 Thesis Subject
The subject must be formally submitted to the Graduate School at the time the student
submits the program of study. Approval of the thesis subject by the student’s advisory
committee is required.
10.2.2 Completed Thesis
An approved electronic copy of the thesis must be submitted to the Graduate School no
later than 24 hours before the final examination. It must have been previously approved
by a committee which shall be appointed by the Dean of the Graduate School. The thesis
shall be read and approved by no fewer than three (3) persons.
The “Tentative Thesis Acceptance Form” signed by the members of the advisory
committee signifies that the draft thesis has been read and is in appropriate form for the
oral defense. The filing of a completed Tentative Thesis Acceptance Form signifies only
that the student’s committee deems the thesis to be in acceptable form for oral defense.
A student may expect that revisions, amendments, or additions may be required based
upon the oral examination. In rare instances, serious difficulties may be discovered
during the oral examination, which result in major revisions in a thesis or dissertation.
(Also see Date of Presentation)
10.2.3 Human Subjects Approval
As required by The University of Maine policy, graduate students who plan to perform
research that involves the use of human subjects must comply with The University of
Maine Policies and Procedures of the Institutional Review Board for the Protection of
Human Subjects (IRB). No research with human subjects shall be conducted until the
Institutional Review Board for the Protection of Human Subjects (IRB) has approved the
research protocol. Responsibility for ensuring compliance with The University of Maine
Human Subjects Review Policy rests with the student’s thesis advisor. Evidence of IRB
approval, if applicable, must be noted on the student’s Final Thesis Acceptance Form.
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Student violations of the Human Subjects Review Policy will be handled on an individual
basis in accordance with existing University of Maine or college/departmental policy.
The inclusion in a thesis or dissertation of data involving human subjects which was
obtained through procedures which did not receive prior approval by the IRB will
ordinarily not be permitted.
10.2.4 Animal Subjects Approval
Graduate students performing research or testing using live vertebrate animals must
obtain the approval of the Institutional Animal Care and Use Committee (IACUC) before
initiating such studies. Responsibility for ensuring compliance with The University of
Maine Policies and Procedures for the Humane Care and Use of Animals rests with the
student’s thesis advisor. Evidence of IACUC approval, if applicable, must be noted on
the student’s Final Thesis Acceptance Form. Student violations of the Policies and
Procedures for the Humane Care and Use of Animals will be handled on an individual
basis in accordance with existing University of Maine or college/departmental policy.
The inclusion in a thesis or dissertation of data involving animal subjects which was
obtained through procedures which did not receive prior approval by the IACUC will
ordinarily not be permitted.
10.3

Form and Preparation of Thesis
It is expected that each department will guide its own students in the selection of the
appropriate manual to be used in order that students will have experience with accepted
practice in their own fields. The specific guidelines for thesis and dissertation
preparation are available from the Graduate School’s website at umaine.edu/graduate.
CAUTION: Do not consult another thesis for guidance. Thesis requirements change.

10.3.1 General
The original copy of the thesis shall be submitted electronically in PDF format to the
Graduate School.
The thesis must be standard, double-spaced throughout, except for quotations, footnotes,
bibliographies, and illustrations, which may be single-spaced. Each page of the thesis
shall have a margin of at least one inch on the left, right, top, and bottom. The only
matter which may be outside these imaginary margin lines is the page number. With the
exception of the Abstract which are not included in the pagination of the thesis, all pages
are assigned page numbers. Small Roman numerals are used for the preliminary pages
following the title page. The title page is the only page in the thesis on which a number is
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I.
A.

Administrative Procedures for Human Subject Research

Introduction
Research with human subjects at the University of Maine shall be guided by three
general ethical principles: respect for persons, beneficence, and justice. These
principles and the rules that may be derived from them shall form the analytical
framework for determining whether and how research with human subjects may
be conducted. Researchers must respect and protect the rights and privacy and
welfare of individuals recruited for and participating in research. More precisely,
all human subject research must comply with the US Department of Health and
Human Services (DHHS) “Common Rule” 45 CFR 46; 21 CFR 50; the Belmont
Report; The Nuremburg Code; and the Declaration of Helsinki.
The University shall maintain and support an Institutional Review Board for the
Protection of Human Subjects (IRB), whose function it is to determine whether
and how research with human subjects may be conducted, and to educate the
community with regard to the protection of human subjects.
No research with human subjects shall be conducted until the IRB has reviewed
the research protocol. Before action is taken, proper consideration shall be given
to the risks to the subjects, the anticipated benefits to the subjects and others, the
importance of the knowledge that may reasonably be expected to result, and the
informed consent process to be employed.
The University of Maine shall acknowledge and accept responsibility for
protecting the rights and welfare of human subjects of research. University
Policies and Procedures for the Protection of Human Subjects of Research apply
to all activities which include research with human subjects and:
-

are sponsored by the University; or

-

are conducted by or under the direction of any faculty, staff
member, or student of the University in connection with his or her
institutional responsibilities; or

-

are conducted by or under the direction of any faculty, staff
member, or student of the University using any property or facility
of the University; or

-

involve the use of the University's nonpublic information.

The University of Maine shall encourage and promote constructive
communication among research administrators, department chairs, deans and
directors, research investigators, research staff, human subjects, and University
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officials as a means of maintaining a high level of awareness regarding the
safeguarding of the rights and welfare of the subjects.
The University of Maine shall comply with all federal, state, and local regulations
pertaining to the protection of human subjects.
B.

C.

Student Class Projects
1.

Class projects that involve systematic collection of data and for which the
design or objective is to develop or contribute to generalizable knowledge
are considered research and require IRB review.

2.

Class projects that are designed: a) solely with the objective of providing
students with training about and experience with research methods, and b)
where data will not be used outside of the classroom context, and c) where
data will be destroyed upon completion of the project, are not considered
research and do not require IRB review. However, if the instructor allows
a student to design a class project that involves protected populations or
sensitive information, IRB review and approval are required. (See
document, Guidelines for Class Projects for additional information.)

Research Activities that May Be Exempt from Further Review
Exempt - The Common Rule outlines certain types of research that are exempt
from Institutional Review Board (IRB) oversight: 45 CFR 46.104(d); 21 CFR 50
and 56 [US Food and Drug Administration (FDA research)]. Only the IRB can
determine if a proposed project qualifies as exempt from further review. Principal
Investigators (PI) whose research is judged exempt from further review are not
required to have any further interaction with the IRB unless adverse events occur,
or there is a substantial change to the protocol.
Exempt Categories:
1.

Research, conducted in established or commonly accepted educational
settings, that specifically involves normal educational practices that are
not likely to adversely impact students’ opportunity to learn required
educational content or the assessment of educators who provide
instruction. This includes most research on regular and special education
instructional strategies, and research on the effectiveness of or the
comparison among instructional techniques, curricula, or classroom
management methods.

2.

Research that only includes interactions involving educational tests
(cognitive, diagnostic, aptitude, achievement), survey procedures,
interview procedures, or observation of public behavior (including visual
or auditory recording) if at least one of the following criteria is met:
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(i)

The information obtained is recorded by the investigator in such a
manner that the identity of the human subjects cannot readily be
ascertained, directly or through identifiers linked to the subjects;

(ii)

Any disclosure of the human subjects’ responses outside the
research would not reasonably place the subjects at risk of criminal
or civil liability or be damaging to the subjects’ financial standing,
employability, educational advancement, or reputation; or

(iii)

The information obtained is recorded by the investigator in such a
manner that the identity of the human subjects can readily
ascertained, directly or through identifiers linked to the subjects,
and an IRB conducts a limited IRB review to make the
determination required by 46.111(a)(7).

3. (i) Research involving benign behavioral interventions in conjunction with the
collection of information from an adult subject through verbal or written
responses (including data entry) or audiovisual recording if the subject
prospectively agrees to the intervention and information collection and at
least one of the following criteria is met:
1)
The information obtained is recorded by the investigator in such a
manner that the identity of the human subjects cannot readily be
ascertained, directly or through identifiers linked to the subjects;
2)
Any disclosure of the human subjects’ responses outside the
research would not reasonably place the subjects at risk of criminal or civil
liability or be damaging to the subjects’ financial standing, employability,
educational advancement, or reputation; or
3)
The information obtained is recorded by the investigator in such a
manner that the identity of the human subjects can readily be ascertained,
directly or through identifiers linked to the subjects, and an IRB conducts
a limited IRB review to make the determination required by 45.111(a)(7).
(ii) For the purpose of this provision, benign behavioral interventions are brief
in duration, harmless, painless, not physically invasive, not likely to have
a significant adverse lasting impact on the subjects, and the investigator
has no reason to think the subjects will find the interventions offensive or
embarrassing. Provided all such criteria are met, examples of such benign
behavioral interventions would include having the subjects play an online
game, having them solve puzzles under various noise conditions, or
having them decide how to allocate a nominal amount of received cash
between themselves and someone else.
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(iii) If the research involves deceiving the subjects regarding the nature or
purposes of the research, this exemption is not applicable unless the
subject authorizes the deception through a prospective agreement to
participate in research in circumstances in which the subject is informed
that he or she will be unaware of or misled regarding the nature or
purposes of the research.
4.

Secondary research for which consent is not required: Secondary research
uses of identifiable private information or identifiable biospecimens, if at
least one of the following criteria is met:
(i) The identifiable private information or identifiable biospecimens are
publicly available;
(ii) Information, which may include information about biospecimens, is
recorded by the investigator in such a manner that the identity of the
human subjects cannot readily be ascertained directly or through
identifiers linked to the subjects, the investigator does not contact the
subjects, and the investigator will not re-identify subjects;
(iii) The research involves only information collection and analysis
involving the investigator's use of identifiable health information when
that use is regulated under 45 CFR parts 160 and 164, subparts A and E,
for the purposes of “health care operations” or “research” as those terms
are defined at 45 CFR 164.501 or for “public health activities and
purposes” as described under 45 CFR 164.512(b); or
(iv) The research is conducted by, or on behalf of, a Federal department or
agency using government-generated or government-collected information
obtained for nonresearch activities, if the research generates identifiable
private information that is or will be maintained on information
technology that is subject to and in compliance with section 208(b) of the
E-Government Act of 2002, 44 U.S.C. 3501 note, if all of the identifiable
private information collected, used, or generated as part of the activity will
be maintained in systems of records subject to the Privacy Act of 1974, 5
U.S.C. 552a, and, if applicable, the information used in the research was
collected subject to the Paperwork Reduction Act of 1995, 44 U.S.C. 3501
et seq.

5.

Research and demonstration projects that are conducted or supported by a
Federal department or agency, or otherwise subject to the approval of
department or agency heads (or the approval of the heads of bureaus or
other subordinate agencies that have been delegated authority to conduct
the research and demonstration projects), and that are designed to study,
evaluate, improve, or otherwise examine public benefit or service
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programs, including procedures for obtaining benefits or services under
those programs, possible changes in or alternatives to those programs or
procedures, or possible changes in methods or levels of payment for
benefits or services under those programs. Such projects include, but are
not limited to, internal studies by Federal employees, and studies under
contracts or consulting arrangements, cooperative agreements, or grants.
Exempt projects also include waivers of otherwise mandatory
requirements using authorities such as sections 1115 and 1115A of the
Social Security Act, as amended.
(i) Each Federal department or agency conducting or supporting the
research and demonstration projects must establish, on a publicly
accessible Federal Web site or in such other manner as the department or
agency head may determine, a list of the research and demonstration
projects that the Federal department or agency conducts or supports under
this provision. The research or demonstration project must be published on
this list prior to commencing the research involving human subjects.
6.

Taste and food quality evaluation and consumer acceptance studies:
(i) If wholesome foods without additives are consumed, or
(ii) If a food is consumed that contains a food ingredient at or below the
level and for a use found to be safe, or agricultural chemical or
environmental contaminant at or below the level found to be safe, by the
Food and Drug Administration or approved by the Environmental
Protection Agency or the Food Safety and Inspection Service of the U.S.
Department of Agriculture.
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D.

Definitions
Adverse Event, Serious: Any unfavorable and unintended sign (including an
abnormal laboratory finding), symptom, or disease temporally associated with the
use of a medical treatment or procedure that may or may not be considered related
to the medical treatment or procedure.
Serious Adverse Events include those that:
-

Are fatal or life threatening;
Result in significant or persistent disability;
Require or prolong hospitalization;
Result in a congenital anomaly/birth defect; or
Represent other significant hazards or potentially serious harm to research
subjects or others, in the opinion of the investigators.

Unexpected Serious Adverse Events are those that have not been described in the:
-

Package insert for a given drug or investigator's brochure (for FDA
investigational agents);
Approved protocol; or
Informed consent document. [21 CFR 312.32(a)]

Adverse Research Event: Adverse research events include a wide spectrum of
events. Adverse events include, but are not limited to:
-

Physical or psychological harm or injuries;
Threats to privacy or safety;
Unusual attrition of human subjects;
Breaches of confidentiality or emotional harms such as the emotional
distress that could be triggered by questions about traumatic life events or
a subject's complaints about the experimental procedures or the conduct of
the investigators.

Certificate of Confidentiality: A discretionary document issued by the National
Institutes of Health (NIH), which helps researchers protect the privacy of human
research participants enrolled in biomedical, behavioral, clinical, and other forms
of sensitive research. Certificates protect against compulsory legal demands, such
as court orders and subpoenas, for identifying information or identifying
characteristics of a research participant. Further information is available at
http://grants1.nih.gov/grants/policy/coc/.
Coercion: To bring about participation in research by force or threat, actual or
perceived, or through any other imbalance of power.
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Common Rule: The federal regulation that is the primary source of human
subjects’ protections. This is the common reference for 45 CFR 46,
PROTECTION OF HUMAN SUBJECTS.
Generalizable Knowledge: Currently, US DHHS Office of Human Research
Protection (OHRP) does not have a formal position on what does and does not
constitute “generalizable knowledge” beyond the language of the Common Rule.
The University of Maine adopts the following definition of generalizable
knowledge:
Generalizable knowledge is information which has the potential to be
expanded from the isolated circumstances in which it is acquired to any
broader context.
Thus, a case study, designed to illuminate the course of a single individual’s
experience generally will not be considered to be developing or contributing to
generalizable knowledge. A series of case studies, intended to lead to
improvements in the management of a particular circumstance or condition,
generally will be considered generalizable knowledge.
Human Subject: “A living individual(s) about whom an investigator (whether
professional or student) conducting research:
(i)
(ii)

Obtains information or biospecimens through intervention or interaction
with the individual, and uses, studies, or analyzes the information or
biospecimens; or
Obtains, uses, studies, analyzes, or generates identifiable private
information or identifiable biospecimens

Institutional Review Board (IRB): A research review committee whose primary
purpose is to review all research involving human subjects and to provide
oversight of human subjects’ protections.
Interaction: A communication or interpersonal contact between investigator and
subject for research purposes.
Intervention: Includes both physical procedures by which information or
biospecimens are gathered (e.g., venipuncture) and manipulations of the subject
or the subject's environment that are performed for research purposes.
Key Research Personnel: Persons who have direct contact with subjects,
contribute to the research in a substantive way, have contact with subjects’
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identifiable data or biological samples (e.g., tissue, blood, urine, plasma, saliva),
or use subjects’ personal information.
Minimal Risk: “The probability and magnitude of harm or discomfort anticipated
in the research are not greater in and of themselves than those ordinarily
encountered in daily living or during the performance of routine physical or
psychological examinations or tests.” [45 CFR 46.102(i)]
Minor: An individual under the age of 18 years.
Minor Changes: Minor changes have no substantive effect upon an approved
protocol or reduce the protocol risk already approved by the IRB. Examples of
minor changes are:
-

Changes in research personnel that do not alter the competence of the
research team to conduct the research, or
Minimal changes in remuneration.

Principal Investigator (PI): Any University of Maine faculty, staff member, or
student so designated in a protocol who is the primary person responsible for all
aspects of the research project and assumes all responsibilities for the results.
Prisoner: Any individual, regardless of age, involuntarily confined or detained in
a penal institution or a parolee detained in a treatment center as a condition of
parole. The term is intended to encompass individuals sentenced to such an
institution under a criminal or civil statute, individuals detained in other facilities
by virtue of statutes or commitment procedures that provide alternatives to
criminal prosecution or incarceration in a penal institution, and individuals
detained pending arraignment, trial, or sentencing. This definition also includes
data from non-publicly available databases and secondary sources. The University
of Maine extends the term “prisoner” to include persons on pre-trial supervised
release, on community supervision or on probation, or who is in any court-ordered
deferred prosecution or diversion program.
Private Information: includes information about behavior that occurs in a
context in which an individual can reasonably expect that no observation or
recording is taking place, and information that has been provided for specific
purposes by an individual and that the individual can reasonably expect will not
be made public (e.g., a medical record).
Identifiable private information is private information for which the identity of
the subject is or may readily be ascertained by the investigator or associated
with the information.
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An identifiable biospecimen is a biospecimen for which the identity of the
subject is or may readily be ascertained by the investigator or associated with
the biospecimen.
Protected Population: (Also referred to as protected subject group). These
groups of potential research subjects have specific regulatory compliance
requirements and receive special protections under the Common Rule and/or other
federal regulations. These groups include (but not restricted to):
-

Children/Minors (under the age of 18)
Prisoners (now includes non-publicly available secondary data)
Pregnant women
Fetuses and products of labor and delivery
People with diminished capacity to give consent
Mentally or physically challenged individuals

Protocol: Any type of research project that is submitted for IRB review (also
known as a research project, proposal, submission, etc.).
Protocol Violation, Major: A major protocol violation occurs when there is a
variance in a research study between the protocol that has been reviewed and
approved by the IRB and the actual activities being performed. Major protocol
violations include violations that:
-

Cause or pose a significant risk of substantive harm to research
participants;
Damage the scientific integrity of the data collected;
Show evidence of willful or knowing misconduct on the part of the
investigator; or
Demonstrate a serious or continued noncompliance with federal, state or
local research policy, laws, or regulations.

Protocol Violation, Minor: A minor protocol violation occurs when there is a
variance in a research study between the protocol that has been reviewed and
approved by the IRB and the actual activities being performed. Minor protocol
violations include violations that:
-

Have no substantive effect on the risks to research participants;
Do not impact the value of the data collected (meaning the violation does
not confound the scientific analysis of the results); and
Do not result from willful or knowing misconduct on the part of the
investigator(s).

Research: The University of Maine takes as its starting point the federal
definition of research set forth in the Common Rule, [45 CFR 46.102(d)]:
9

Research means a systematic investigation, including research
development, testing and evaluation, designed to develop or
contribute to generalizable knowledge. Activities that meet this
definition constitute research for purposes of this policy, whether
or not they are conducted or supported under a program that is
considered research for other purposes. For example, some
demonstration and service programs may include research
activities). Please note that risk assessment plays no role in the
determination of whether a proposed activity constitutes
research. See also the definition of generalizable knowledge,
above.
For purposes of this part, the following activities are deemed not to
be research:
(1) Scholarly and

journalistic activities (e.g., oral history, journalism,
biography, literary criticism, legal research, and historical scholarship), including
the collection and use of information, that focus directly on the specific
individuals about whom the information is collected.
(2) Public health surveillance activities, including the collection and
testing of information or biospecimens, conducted, supported, requested, ordered,
required, or authorized by a public health authority. Such activities are limited to
those necessary to allow a public health authority to identify, monitor, assess, or
investigate potential public health signals, onsets of disease outbreaks, or
conditions of public health importance (including trends, signals, risk factors,
patterns in diseases, or increases in injuries from using consumer products). Such
activities include those associated with providing timely situational awareness and
priority setting during the course of an event or crisis that threatens public health
(including natural or man-made disasters).
(3) Collection and analysis of information, biospecimens, or records by or
for a criminal justice agency for activities authorized by law or court order solely
for criminal justice or criminal investigative purposes.
(4) Authorized operational activities (as determined by each agency) in
support of intelligence, homeland security, defense, or other national security
missions.

Research Misconduct (42 CFR §93.103): means fabrication, falsification, or
plagiarism in proposing, performing, or reviewing research, or in reporting
research results.
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-

Fabrication is making up data or results and recording or reporting them as
if they were real.
Falsification is manipulating research materials, equipment, or processes,
or changing or omitting data or results such that the research is not
accurately represented in the research record.
Plagiarism is the appropriation of another person's ideas, processes,
results, or words without giving appropriate credit.
Research misconduct does not include honest error or differences of
opinion.

Sensitive Information: According to the NIH Certificate of Confidentiality
Kiosk, sensitive information is that which, if disclosed, may reasonably pose a
risk to the subject’s psychological, social, medical, legal, or economic well-being
or quality of life. Categories of sensitive information include (but are not limited
to):
-

Sexual attitudes, preferences, or practices
Use of alcohol, drugs, or other addictive products
Information pertaining to illegal conduct
Information that if released might be damaging to an individual’s financial
standing, employability, or reputation within the community or might lead
to social stigmatization or discrimination
Health and medical information contained in a medical record, chart, or
insurance file (this category may also require a HIPAA review)
Information pertaining to an individual's psychological well-being or
mental health (this category may also require a HIPAA review)
Genetic information or tissue samples (this category may also require a
HIPAA review)

Signatory/Institutional Official: The signatory/institutional official (IO) is the
highest institutional official who has the legal authority to represent the
University of Maine’s Assurance filed with the OHRP, and is responsible for the
provisions of this policy. At the University of Maine, the signatory/institutional
official is the Vice President for Research.
Specimen: Specimen is used to refer to biological specimens (e.g., blood or tissue
samples), as well as to other types of data "specimens" that could be stored for use
in future research (e.g., audio tapes, video tapes, etc.).
Substantive Changes Affecting Risk: Substantive changes are changes that may
increase the research population's risk or are of questionable risk. Examples of
substantive changes that are considered to increase the risk to the study/individual
include, but are not limited to:
-

Increasing the length of time a study participant is exposed to
experimental aspects of the study.
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-

Changing the originally targeted population to include a more at-risk
population (e.g., previous exclusion for those with renal failure are now
allowed to enroll, or adding children or pregnant women to the study).
Adding an element that may breach the confidentiality of the subject such
as tissue banking or genetic testing.

Undue Influence: Inappropriate remuneration or any other form of compulsion
offered to an individual that may unfairly compel that individual to participate as
a human research subject.
Unanticipated Problem: Any event that is not expected given the nature of the
research procedures and the subject population being studied, and places subjects
or others at greater risk or harm/discomfort related to the research than was
previously known or recognized. An event which was previously unforeseeable
based on the information provided to the IRB.
Written or in writing: refers to writing on a tangible medium (e.g., paper) or in
an electronic format.
E.

Responsibilities of the Principal Investigator
The individual faculty, staff member, or student of the University who conducts
or directs research with human subjects exercises the following responsibilities:
1.

The Principal Investigator shall submit an application for Approval of
Research with Human Subjects to the Board. The application includes all
criteria for submission.

2.

The Principal Investigator and personnel named in the application or who
will have access to data, shall complete the required training.

3.

The Principal Investigator shall begin the research project ONLY after
receiving written approval from the IRB.

4.

The Principal Investigator shall make no alterations to the approved
protocol without the prior approval of such alterations by the IRB.

5.

The Principal Investigator shall report at once to the IRB any
unanticipated harm to human subjects.

6.

The Principal Investigator shall submit a status report to the IRB on the
conduct of the research and shall seek approval for continuation of the
research at least annually, and more frequently if the IRB so requires.

7.

The Principal Investigator shall cooperate fully with the Protection of
Human Subjects Review Board in monitoring the progress of the research.

12

F.

IRB Membership
The IRB is responsible not only for reviewing, regulating, and monitoring human
subject research but also for educating the University community in the protection
of human subjects.
1.

The IRB shall have no fewer than five voting members, with varying
backgrounds to promote complete and adequate review of research
activities commonly conducted by the institution. The IRB shall be
sufficiently qualified through the experience and expertise of its members,
and the diversity of the members, including consideration of race, gender,
and cultural backgrounds and sensitivity to such issues as community
attitudes, to promote respect for its advice and counsel in safeguarding the
rights and welfare of human subjects.

2.

A list of IRB members identified by name; earned degrees; representative
capacity; indications of experience such as board certifications, licenses,
etc., sufficient to describe each member’s chief anticipated contributions
to IRB deliberations; and any employment or other relationship between
each member and the institution, e.g., full-time employee, part-time
employee, member of governing panel or board, stockholder, paid or
unpaid consultant. Changes in IRB membership shall be reported to US
DHHS’s OHRP.

3.

The IRB shall include at least one member whose primary concerns are in
scientific areas and at least one member whose primary concerns are in
nonscientific areas. The IRB shall include at least one member who is not
otherwise affiliated with the institution and who is not part of the
immediate family of a person who is affiliated with the institution. At least
one member’s area of expertise shall include children. At least one
member shall be a prisoner, or a prisoner representative with appropriate
background and experience to serve in that capacity. The IRB may NOT
have a member participate in the initial or continuing review of any
project in which the member has a conflicting interest, except to provide
information requested by the IRB. The IRB may invite individuals with
competence in special areas to assist in the review of issues that require
expertise beyond or in addition to that available to the IRB; such
individuals may not vote with the IRB.

4.

Members are appointed for one to three-year terms and may be
reappointed to additional terms.

5.

All IRB members are formally confirmed by the President (or designee) of
the University; any designation must be specific and in writing.
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6.

G.

The Chair of the IRB should be a tenured faculty member with experience
in conducting human subject research. Appointment is confirmed
officially by the President or designee and is for two years; may be
reappointed to additional terms. A Vice Chair may be appointed, if
desired, using the same confirmation procedure.

IRB Functions and Operations
The IRB shall:

H.

1.

Follow written procedures in the same detail as described in 45 CFR
46.103(b)(4), and to the extent required by 45 CFR 46.103(b)(5).

2.

Except when an expedited review procedure is used (see section I.),
review proposed research at convened meetings at which a majority of the
members of the IRB are present, including at least one member whose
primary concerns are in nonscientific areas. In order for the research to be
approved, it shall receive the approval of a majority of those members
present at the meeting

IRB Review of Research
1.

All research shall be reviewed by the IRB. The IRB shall make the final
decision on whether research is exempt from further review or meets the
requirements for an expedited review. The IRB shall review protocol
applications and has the authority to approve, require modifications, or
disapprove research activities with human subjects.

2.

Ensures that legally effective informed consent of human research subjects
will be obtained in a manner and method that meets the requirements of
federal, state, and local rules and laws and in accordance with section K.

3.

The IRB shall require documentation of informed consent or may waive
documentation in accordance with section L.

4.

The IRB shall notify investigators and the Institutional Official in writing
of its decision to approve or disapprove the proposed research activity, or
of modifications required to secure IRB approval of the research activity.
If the IRB decides to disapprove a research activity, it shall include in its
written notification a statement of the reasons for its decision and give the
investigator an opportunity to respond in person or in writing.

5.

The IRB shall monitor the research it has approved by any means it deems
appropriate, including observation of the consent process and the research
activities and appointment of a third party to undertake such observations.
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6.

The IRB shall conduct continuing review of approved research activities at
intervals appropriate to the degree of risk, but not less than once per year,
except as described in 7 below

7.

Unless an IRB determines otherwise, continuing review of research is not
required in the following circumstances:
i)
ii)
iii)

Research eligible for expedited review in accordance with 46.110.
Research reviewed by the IRB in accordance with the limited IRB
review described in 46.111
Research that has progressed to the point that it involves only one
or both of the following, which are part of the IRB-approved study:
(a) Data analysis, including analysis of identifiable private
information or identifiable biospecimens, or
(b) Accessing follow-up clinical data from procedures that subjects
would undergo as part of clinical care

8.
I.

An IRB shall have authority to observe or have a third party observe the
consent process and the research.

Expedited Review Procedures
1.

Following is a list of categories of research that may be reviewed by the
IRB through an expedited review procedure. Investigators may request an
expedited review when proposed research activities meet one or more of
these categories. Ten business days are required for an expedited review.
(Note: projects falling into one of the exemption categories – section C. -will routinely be expedited.)

2.

Applicability
a.

Research activities that (i) present no more than minimal risk to
human subjects, and (ii) involve only procedures listed in one or
more of the categories detailed below, may be reviewed by the IRB
through the expedited review procedure authorized by 45 CFR
46.110 and 21 CFR 56.110. The activities listed should not be
deemed to be of minimal risk simply because they are included on
this list. Inclusion on this list merely means that the activity is
eligible for review through the expedited review procedure when
the specific circumstances of the proposed research involve no
more than minimal risk to human subjects.

b.

The categories in this list apply regardless of the age of subjects,
except as noted.
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3.

c.

The expedited review procedure may not be used where
identification of the subjects and/or their responses would
reasonably place them at risk of criminal or civil liability or be
damaging to the subjects’ financial standing, employability,
insurability, reputation, or be stigmatizing, unless reasonable and
appropriate protections will be implemented so that risks related to
invasion of privacy and breach of confidentiality are no greater
than minimal.

d.

The expedited review procedure may not be used for classified
research involving human subjects.

e.

IRBs are reminded that the standard requirements for informed
consent (or its waiver, alteration, or exception) apply regardless of
the type of review--expedited or convened--utilized by the IRB.

f.

Research categories 3.a. through 3.g. below pertain to both initial
and continuing IRB review.

Research Categories
a.

b.

Clinical studies of drugs and medical devices only when condition
1) or 2) is met.
1)

Research on drugs for which an investigational new drug
application (21 CFR part 312) is not required. (Note:
research on marketed drugs that significantly increases the
risks or decreases the acceptability of the risks associated
with the use of the product is not eligible for expedited
review.)

2)

Research on medical devices for which (i) an
investigational device exemption application (21 CFR part
812) is not required; or (ii) the medical device is
cleared/approved for marketing, and the medical device is
being used in accordance with its cleared/approved
labeling.

Collection of blood samples by finger stick, heel stick, ear stick, or
venipuncture as follows:
1)

from healthy, nonpregnant adults who weigh at least 110
pounds. For these subjects, the amounts drawn may not
exceed 550 ml in an 8-week period and collection may not
occur more frequently than 2 times per week; or
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2)

c.

from other adults and children, considering the age, weight,
and health of the subjects, the collection procedure, the
amount of blood to be collected, and the frequency with
which it will be collected. For these subjects, the amount
drawn may not exceed the lesser of 50 ml or 3 ml per kg in
an 8-week period and collection may not occur more
frequently than 2 times per week.

Prospective collection of biological specimens for research
purposes by noninvasive means.
Examples: (a) hair and nail clippings in a nondisfiguring manner;
(b) deciduous teeth at time of exfoliation or if routine patient care
indicates a need for extraction; (c) permanent teeth if routine
patient care indicates a need for extraction; (d) excreta and external
secretions (including sweat); (e) uncannulated saliva collected
either in an unstimulated fashion or stimulated by chewing
gumbase or wax or by applying a dilute citric solution to the
tongue; (f) placenta removed at delivery; (g) amniotic fluid
obtained at the time of rupture of the membrane prior to or during
labor; (h) supra- and subgingival dental plaque and calculus,
provided the collection procedure is not more invasive than routine
prophylactic scaling of the teeth and the process is accomplished in
accordance with accepted prophylactic techniques; (i) mucosal and
skin cells collected by buccal scraping or swab, skin swab, or
mouth washings; (j) sputum collected after saline mist
nebulization.

d.

Collection of data through noninvasive procedures (not involving
general anesthesia or sedation) routinely employed in clinical
practice, excluding procedures involving x-rays or microwaves.
Where medical devices are employed, they must be
cleared/approved for marketing. Studies intended to evaluate the
safety and effectiveness of the medical device are not generally
eligible for expedited review, including studies of cleared medical
devices for new indications.
Examples: (a) physical sensors that are applied either to the surface
of the body or at a distance and do not involve input of significant
amounts of energy into the subject or an invasion of the subject’s
privacy; (b) weighing or testing sensory acuity; (c) magnetic
resonance imaging; (d) electrocardiography,
electroencephalography, thermography, detection of naturally
occurring radioactivity, electroretinography, ultrasound, diagnostic
infrared imaging, doppler blood flow, and echocardiography; (e)
moderate exercise, muscular strength testing, body composition
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assessment, and flexibility testing where appropriate given the age,
weight, and health of the individual.
e.

Research involving materials (data, documents, records, or
specimens) that have been collected, or will be collected solely for
nonresearch purposes (such as medical treatment or diagnosis).
(NOTE: Some research in this category may be exempt from the
DHHS regulations for the protection of human subjects. [45 CFR
46.101(b)(4)]. This listing refers only to research that is not
exempt.)

f.

Collection of data from voice, video, digital, or image recordings
made for research purposes.

g.

Research on individual or group characteristics or behavior
(including, but not limited to, research on perception, cognition,
motivation, identity, language, communication, cultural beliefs or
practices, and social behavior) or research employing survey,
interview, oral history, focus group, program evaluation, human
factors evaluation, or quality assurance methodologies. (NOTE:
Some research in this category may be exempt from the DHHS
regulations for the protection of human subjects. [45 CFR
46.101(b)(2) and (b)(3)]. This listing refers only to research that is
not exempt.)

h.

Continuing review of research previously approved by the
convened IRB as follows:

i.

1)

where(i) the research is permanently closed to the
enrollment of new subjects; (ii) all subjects have completed
all research-related interventions; and (iii) the research
remains active only for long-term follow-up of subjects; or

2)

where no subjects have been enrolled and no additional
risks have been identified; or

3)

where the remaining research activities are limited to data
analysis.

Continuing review of research, not conducted under an
investigational new drug application or investigational device
exemption where research categories 3.b. through 3.h. do not
apply, but the IRB has determined and documented at a convened
meeting that the research involves no greater than minimal risk and
no additional risks have been identified.
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4.

The IRB may use the expedited review procedure to review either or both
of the following:
a.

some or all of the research appearing on the list and found by the
reviewer(s) to involve no more than minimal risk;

b.

minor changes in previously approved research during the period
(of one year or less) for which approval is authorized.

Under an expedited review procedure, the review may be carried out by
the IRB chairperson or by one or more experienced reviewers designated
by the chairperson from among members of the IRB. In reviewing the
research, the reviewers may exercise all of the authorities of the IRB
except that the reviewers may not disapprove the research. A research
activity may be disapproved only after review in accordance with the nonexpedited procedure set forth in §46.108(b).

J.

5.

The IRB shall keep all members advised of research proposals that have
been approved under the expedited review procedure by including a list of
those proposals on the monthly agenda and subsequent minutes.

6.

The department or agency heads 1 may restrict, suspend, terminate, or
choose not to authorize an institution's or IRB's use of the expedited
review procedure.

Criteria for IRB Approval of Research
The IRB approves research only when it has determined that all of the following
requirements are satisfied:
1.

Risks to subjects are minimized. Procedures used are consistent with
sound research design and do not unnecessarily expose subjects to risk.
Whenever appropriate, the research uses procedures already being
performed on the subjects for other purposes, such as diagnosis or
treatment.

2.

Risks to subjects are reasonable in relation to anticipated benefits, if any,
to the subjects, and the importance of the knowledge that may reasonably
be expected to result. The IRB considers only those risks and benefits that
may result from the research. The IRB does not consider possible longrange effects of applying knowledge gained in the research as among
those research risks that fall within the purview of its responsibility.

1

“Department or Agency heads” refers specifically to the heads of various federal
departments or agencies, and not state government officials or campus department heads.
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K.

3.

The selection of subjects is equitable, taking into account the purpose of
the research and the setting in which the research will be conducted.

4.

Informed consent is sought from each prospective subject or the subject’s
legally authorized representative. The IRB conforms to federal regulations
of informed consent procedures and may impose additional requirements.

5.

Informed consent is appropriately documented or appropriately waived, in
accordance with, and to the extent required by, federal regulations. The
IRB may also impose documentation requirements in addition to those
required by federal regulations.

6.

When appropriate, the research protocol makes adequate provision for
monitoring the data collected to insure the safety of subjects.

7.

When appropriate, there are adequate provisions to protect the privacy of
subjects and to maintain the confidentiality of data.

8.

When some or all of the subjects are likely to be vulnerable to coercion or
undue influence, appropriate additional safeguards have been included in
the protocol to protect the rights and welfare of these subjects.

General Requirements for Informed Consent
Except as provided elsewhere in this policy, no investigator may involve a human
being as a subject in research covered by this policy unless the investigator has
obtained the legally effective informed consent of the subject or the subject's
legally authorized representative. An investigator shall seek such consent only
under circumstances that provide the prospective subject or the representative
sufficient opportunity to consider whether or not to participate and that minimize
the possibility of coercion or undue influence. The information that is given to the
subject or the representative shall be in language understandable to the subject or
the representative. No informed consent, whether oral or written, may include any
exculpatory language through which the subject or the representative is made to
waive or appear to waive any of the subject's legal rights, or releases or appears to
release the investigator, the sponsor, the institution or its agents from liability for
negligence.
1.

Basic elements of informed consent. Except as provided in paragraph 3. or
4. of this section, in seeking informed consent the following information
shall be provided to each subject:
a.

A statement that the study involves research, an explanation of the
purposes of the research and the expected duration of the subject's
participation, a description of the procedures to be followed, and
identification of any procedures that are experimental;
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2.

b.

A description of any reasonably foreseeable risks or discomforts to
the subject;

c.

A description of any benefits to the subject or to others which may
reasonably be expected from the research;

d.

A disclosure of appropriate alternative procedures or courses of
treatment, if any, that might be advantageous to the subject;

e.

A statement describing the extent, if any, to which confidentiality
of records identifying the subject will be maintained;

f.

For research involving more than minimal risk, an explanation as
to whether any compensation and an explanation as to whether any
medical treatments are available if injury occurs and, if so, what
they consist of, or where further information may be obtained;

g.

An explanation of whom to contact for answers to pertinent
questions about the research and research subjects' rights, and
whom to contact in the event of a research-related injury to the
subject; and

h.

A statement that participation is voluntary; refusal to participate
will involve no penalty or loss of benefits to which the subject is
otherwise entitled, and the subject may discontinue participation at
any time without penalty or loss of benefits to which the subject is
otherwise entitled.

Additional elements of informed consent. When appropriate, one or more
of the following elements of information shall also be provided to each
subject:
a.

A statement that the particular treatment or procedure may involve
risks to the subject (or to the embryo or fetus, if the subject is or
may become pregnant) that are currently unforeseeable;

b.

Anticipated circumstances under which the subject's participation
may be terminated by the investigator without regard to the
subject's consent;

c.

Any additional costs to the subject that may result from
participation in the research;
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3.

4.

5.

d.

The consequences of a subject's decision to withdraw from the
research and procedures for orderly termination of participation by
the subject;

e.

A statement that significant new findings developed during the
course of the research that may relate to the subject's willingness to
continue participation will be provided to the subject; and

f.

The approximate number of subjects involved in the study.

The IRB may approve a consent procedure that does not include, or which
alters, some or all of the elements of informed consent set forth above, or
waive the requirement to obtain informed consent provided the IRB finds
and documents that:
a.

The research or demonstration project is to be conducted by or
subject to the approval of state or local government officials and is
designed to study, evaluate, or otherwise examine: (i) public
benefit or service programs; (ii) procedures for obtaining benefits
or services under those programs; (iii) possible changes in or
alternatives to those programs or procedures; or (iv) possible
changes in methods or levels of payment for benefits or services
under those programs; and

b.

The research could not practicably be carried out without the
waiver or alteration.

The IRB may approve a consent procedure which does not include, or
which alters, some or all of the elements of informed consent set forth in
this section, or waive the requirements to obtain informed consent
provided the IRB finds and documents that:
a.

The research involves no more than minimal risk to the subjects;
and

b.

The waiver or alteration will not adversely affect the rights and
welfare of the subjects; and

c.

The research could not practicably be carried out without the
waiver or alteration; and

d.

Whenever appropriate, the subjects will be provided with
additional pertinent information after participation.

The informed consent requirements in this policy are not intended to
preempt any applicable federal, state, or local laws that require additional
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information to be disclosed in order for informed consent to be legally
effective.
6.

L.

Nothing in this policy is intended to limit the authority of a physician to
provide emergency medical care, to the extent the physician is permitted
to do so under applicable federal, state, or local law.

Documentation of Informed Consent
1.

Except as provided in paragraph 3. of this section, informed consent shall
be documented by the use of a written consent form approved by the IRB
and signed by the subject or the subject’s legally authorized
representative. A copy shall be given to the person signing the form.

2.

Except as provided in paragraph 3. of this section, the consent form may
be either of the following:

3.

a.

A written consent document that embodies the elements of
informed consent required by section K. This form may be read to
the subject or the subject’s legally authorized representative, but in
any event, the investigator shall give either the subject or the
representative adequate opportunity to read it before it is signed; or

b.

A short written consent document stating that the elements of
informed consent required by section K. have been presented
orally to the subject or the subject’s legally authorized
representative. When this method is used, there shall be a witness
to the oral presentation. Also, the IRB shall approve a written
summary of what is to be said to the subject or the representative.
Only the short form itself is to be signed by the subject or the
representative. However, the witness shall sign both the short form
and a copy of the summary, and the person actually obtaining
consent shall sign a copy of the summary. A copy of the summary
shall be given to the subject or the representative, in addition to a
copy of the short form.

The IRB may waive the requirement for the investigator to obtain a signed
consent form for some or all subjects if it finds either:
a.

That the only record linking the subject and the research would be
the consent document, and the principal risk would be potential
harm resulting from a breach of confidentiality. Each subject will
be asked whether the subject wants documentation linking the
subject with the research, and the subject’s wishes will govern; or
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b.

That the research presents no more than minimal risk of harm to
subjects and involves no procedures for which written consent is
normally required outside of the research context.

In cases in which the documentation requirement is waived, the IRB may
require the investigator to provide subjects with a written statement
regarding the research.
M.

Assurance of Compliance
The University of Maine conducts federally funded non-exempt human subject
research; as such, it has a legally binding agreement with US DHHS -- a Federal
Wide Assurance. This Federal Wide Assurance is administered by US DHHS’s
OHRP and governs all human subject research receiving, or eligible to receive
federal (US DHHS) funds. This agreement is guided by the ethical principles of
the Belmont Report and requires, at a minimum, compliance with 45 CFR 46 (The
Common Rule). The University of Maine’s Federal Wide Assurance number is:
FWA00000479.

N.

Review by Institution
Research covered by this policy that has been approved by the IRB may be
subject to further appropriate review and approval or disapproval by officials of
the institution. However, those officials may not approve the research if it has not
been approved by the IRB.

O.

Suspension or Termination of IRB Approval of Research
The IRB has authority to suspend or terminate approval of research that is not
being conducted in accordance with the IRB’s requirements or that has been
associated with unexpected serious harm to subjects. When the IRB exercises this
authority, it promptly communicates its action and the reasons for the action in
writing to the Principal Investigator, Institutional Official or other appropriate
campus official, and the extramural sponsor of the research, if any.

P.

Cooperative Research
Cooperative research projects are those projects covered by this policy, or the
Common Rule, involving more than one institution, whether within UMaine
System campuses or other institutions outside the System. In the conduct of
cooperative research projects, each institution is responsible for safeguarding the
rights and welfare of human subjects and for complying with this policy. A
campus participating in a cooperative project may enter into a joint review
arrangement with another campus IRB, rely upon the review of another qualified
IRB, or make similar arrangements for avoiding duplication of effort.
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Q.

IRB Records
1.

2.

R.

The IRB shall prepare and maintain adequate documentation of its
activities, including the following:
a.

Copies of all research proposals reviewed, scientific evaluations, if
any, that accompany the proposals, approved sample consent
documents, progress reports submitted by investigators, and
reports of injuries to subjects.

b.

Minutes of IRB meetings shall be in sufficient detail to show
attendance at the meetings; actions taken by the IRB; votes on
actions including the number of members voting for, against, and
abstaining; basis for requiring changes in or disapproving research;
and a written summary of the discussion of controverted issues and
their resolution.

c.

Records of continuing review activities.

d.

Copies of all correspondence between the IRB and the investigator.

e.

A list of all IRB members in the same detail as described in section
F.

f.

Written procedures for the IRB in the same detail as described in
§46.103(b)(4) and §46.103(b)(5).

g.

Statements of significant new findings provided to subjects, as
required by §46.103(b)(5).

The records required by this policy shall be retained for at least 3 years;
and records relating to research that is conducted shall be retained for at
least 3 years after completion of the research. All records shall be
accessible for inspections and copying by authorized representatives of US
DHHS OHRP at reasonable times and in a reasonable manner.

Applications and Proposals Lacking Definite Plans for Involvement of
Human Subjects
Certain types of research proposals may not have fully defined plans set forth in
the application or proposal. Such proposals may include institutional type grants
when selection of specific projects is the institution's responsibility; research
training grants in which the activities involving subjects remain to be selected;
and projects in which human subjects' involvement will depend upon completion
of instruments, prior animal studies, or purification of compounds. These
applications need not be reviewed by the IRB before an application for award can
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be filed, nor before an award may be made. However, no human subjects may be
involved in any project supported by these awards until the project has been
reviewed and approved by the IRB.
S.

Research Undertaken without the Intention of Involving Human Subjects
In the event research is undertaken without the intention of involving human
subjects, but it is later proposed to involve human subjects in the research, the
research shall first be reviewed and approved by the IRB.

T.

Use of Federal Funds
Federal funds administered by a department or agency may not be expended for
research involving human subjects unless the requirements of this policy have
been satisfied.

U.

V.

Early Termination of Research Support: Evaluation of Applications
and Proposals
1.

The IRB, senior administrator responsible for the IRB, or the UMaine
System may terminate or suspend an approved project if an investigator
has failed to comply with the terms of this policy.

2.

The IRB, senior administrator responsible for the IRB, or the UMaine
System may take into account, in addition to all other eligibility
requirements and program criteria, factors such as whether the applicant
has been subject to a termination or suspension under paragraph 1. of this
section and whether the applicant or the person or persons who would
direct or has/have directed the scientific and technical aspects of an
activity has/have in their judgment materially failed to discharge
responsibility for the protection of the rights and welfare of human
subjects (whether or not the research was subject to federal regulation).

Conditions
With respect to any research project or any class of research projects, the senior
administrator responsible for the IRB or the UMaine System may impose
additional conditions necessary for the protection of human subjects.
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II.
A.

B.

Research Involving Children

Applicability
1.

The regulations in this section are applicable to all biomedical and
behavioral research involving children conducted by any member of the
University of Maine.

2.

All research involving children as subjects must comply with any state or
local laws limiting such research.

3.

The requirements of this section are in addition to those imposed under the
other sections of the University of Maine Policies and Procedures for the
Protection of Human Subjects of Research.

4.

Note that the exemptions described in section C. of Administrative
Procedures for Human Subjects Research and at 45 CFR 46.101(b)(1) and
(b)(3) through (b)(6) are applicable to this section. The exemption at
§46.101(b)(2) regarding educational tests is also applicable to this section.
However, the exemption at §46.101(b)(2) for research involving survey or
interview procedures or observations of public behavior does not apply to
research covered by this section, except for research involving observation
of public behavior when the investigator(s) do not participate in the
activities being observed.

Definitions
As used in this section:
1.

Children are persons who have not attained the legal age for consent to
treatments or procedures involved in the research, under the applicable
law of the jurisdiction in which the research will be conducted.

2.

Assent means a child's affirmative agreement to participate in research.
Mere failure to object should not, absent affirmative agreement, be
construed as assent.

3.

Permission means the agreement of parent(s) or guardian to the
participation of their child or ward in research.

4.

Parent means a child's biological or adoptive parent.

5.

Guardian means an individual who is authorized under applicable state or
local law to consent on behalf of a child to general medical care.
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C.

Special IRB Duties
In addition to other responsibilities assigned to the IRB in this section, the IRB
shall review research covered by this section and approve only research that
satisfies the conditions of all applicable parts of this section.

D.

Research not Involving Greater than Minimal Risk (45 CFR 46.404)
Research in which the IRB finds no greater than minimal risk to children to be
present may be approved only if the IRB finds that adequate provisions are made
for soliciting the assent of the children and the permission of their parents or
guardians, as set forth below.

E.

Research Involving Greater than Minimal Risk but Presenting the Prospect
of Direct Benefit to the Individual Subject (45 CFR 46.405)
If the IRB finds that more than minimal risk to children is presented by an
intervention or procedure that holds out the prospect of direct benefit for the
individual subject, or by a monitoring procedure that is likely to contribute to the
subject's well-being, the proposed research may be approved only if the IRB finds
that:

F.

1.

The risk is justified by the anticipated benefit to the subjects;

2.

The relation of the anticipated benefit to the risk is at least as favorable to
the subjects as that presented by available alternative approaches; and

3.

Adequate provisions are made for soliciting the assent of the children and
permission of their parents or guardians as set forth in H. in this section.
[§46.408]

Research Involving Greater than Minimal Risk and no Prospect of Direct
Benefit to the Individual Subject, but likely to Yield Generalizable
Knowledge about the Subject’s Disorder or Condition (45 CFR 46.406)
If the IRB finds that more than minimal risk to children is presented by an
intervention or procedure that does not hold out the prospect of direct benefit for
the individual subject, or by a monitoring procedure that is not likely to contribute
to the well-being of the subject, the proposed research may be approved only if
the IRB finds that:
1.

The risk represents a minor increase over minimal risk;

2.

The intervention or procedure presents experiences to subjects that are
reasonably commensurate with those inherent in their actual or expected
medical, dental, psychological, social, or educational situations;
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G.

3.

The intervention or procedure is likely to yield generalizable knowledge
about the subjects' disorder or condition that is of vital importance for the
understanding or amelioration of the subjects' disorder or condition; and

4.

Adequate provisions are made for soliciting assent of the children and
permission of their parents or guardians as set forth in H. in this section.
[§46.408]

Research not Otherwise Approvable that Presents an Opportunity to
Understand, Prevent, or Alleviate a Serious Problem Affecting the Health or
Welfare of Children (45 CFR 46.407)
If the IRB does not think the proposed research meets the requirements of the
three immediately preceding conditions, research may only be approved if:
1.

The IRB finds that the research presents a reasonable opportunity to
further the understanding, prevention, or alleviation of a serious problem
affecting the health or welfare of children; and

2.

The Secretary of US DHHS, after consultation with a panel of experts in
pertinent disciplines (for example: science, medicine, education, ethics,
law) and following opportunity for public review and comment, has
determined either:
a.
b.

H.

The research in fact satisfies the conditions in D., E., or F. in this
section [§46.404, §46.405, or §46.406], as applicable, or
the following:
1)

the research presents a reasonable opportunity to further the
understanding, prevention, or alleviation of a serious
problem affecting the health or welfare of children;

2)

the research will be conducted in accordance with sound
ethical principles;

3)

adequate provisions are made for soliciting the assent of
children and the permission of their parents or guardians, as
set forth in H. in this section.

Requirements for Permission by Parents or Guardians and for Assent by
Children (45 CFR 46.408)
1.

In addition to the determinations required under other applicable sections
of this section, the IRB shall determine that adequate provisions are made
for soliciting the assent of the children, when in the judgment of the IRB
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the children are capable of providing assent. In determining whether
children are capable of assenting, the IRB shall take into account the ages,
maturity, and psychological state of the children involved. This judgment
may be made for all children to be involved in research under a particular
protocol, or for each child, as the IRB deems appropriate. If the IRB
determines that the capability of some or all of the children is so limited
that they cannot reasonably be consulted or that the intervention or
procedure involved in the research holds out a prospect of direct benefit
that is important to the health or well-being of the children and is available
only in the context of the research, the assent of the children is not a
necessary condition for proceeding with the research. Even where the IRB
determines that the subjects are capable of assenting, the IRB may still
waive the assent requirement under circumstances in which consent may
be waived in accord with section K. of the Administrative Procedures for
Human Subject Research. (45 CFR 46.116)
2.

In addition to the determinations required under other applicable parts of
this section, the IRB shall determine, in accordance with and to the extent
that consent is required by K. of the Administrative Procedures for Human
Subject Research (§46.116), that adequate provisions are made for
soliciting the permission of each child's parents or guardian. Where
parental permission is to be obtained, the IRB may find that the
permission of one parent is sufficient for research to be conducted under
D. and E. in this section [§46.404 or §46.405]. Where research is covered
by F. and G. in this section [§46.406 and §46.407] and permission is to be
obtained from parents, both parents must give their permission unless one
parent is deceased, unknown, incompetent, or not reasonably available, or
when only one parent has legal responsibility for the care and custody of
the child.

3.

In addition to the provisions for waiver contained in L. [§46.116] of the
Administrative Procedures for Human Subject Research, if the IRB
determines that a research protocol is designed for conditions or for a
subject population for which parental or guardian permission is not a
reasonable requirement to protect the subjects (for example, neglected or
abused children), it may waive the consent requirements in A. in this
section and paragraph 2. above provided an appropriate mechanism for
protecting the children who will participate as subjects in the research is
substituted, and provided further that the waiver is not inconsistent with
federal, state, or local law. The choice of an appropriate mechanism would
depend upon the nature and purpose of the activities described in the
protocol, the risk and anticipated benefit to the research subjects, and their
age, maturity, status, and condition.
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I.

4.

Permission by parents or guardians shall be documented in accordance
with and to the extent required by L. [§46.117] of the Administrative
Procedures for Human Subject Research.

5.

When the IRB determines that assent is required, it shall also determine
whether and how assent must be documented.

Wards
1.

2.

Children who are wards of the state or any other agency, institution, or
entity can be included in research approved under F. and G. in this section
(§46.406 or §46.407) only if such research is:
a.

Related to their status as wards; or

b.

Conducted in schools, camps, hospitals, institutions, or similar
settings in which the majority of children involved as subjects are
not wards.

If the research is approved under paragraph 1. above, the IRB shall require
appointment of an advocate for each child who is a ward, in addition to
any other individual acting on behalf of the child as guardian or in loco
parentis. One individual may serve as advocate for more than one child.
The advocate shall be an individual who has the background and
experience to act in, and agrees to act in, the best interests of the child for
the duration of the child's participation in the research and who is not
associated in any way (except in the role as advocate or member of the
IRB) with the research, the investigator(s), or the guardian organization.
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III.
A.

B.

Research Involving Prisoners

Applicability
1.

The regulations in this section are applicable to all biomedical and
behavioral research involving prisoners conducted by any member of the
University of Maine.

2.

All research involving prisoners as subjects must comply with any state or
local laws limiting such research.

3.

The requirements of this section are in addition to those imposed under the
other sections of the University of Maine Policies and Procedures for the
Protection of Human Subjects of Research.

Purpose
Inasmuch as prisoners may be under constraints because of their incarceration,
which could affect their ability to make a truly voluntary and uncoerced decision
whether or not to participate as subjects in research, it is the purpose of this
section to provide additional safeguards for the protection of prisoners involved in
activities to which this section is applicable.

C.

Definitions
As used in this section:
1.

Prisoner means any individual involuntarily confined or detained in a
penal institution. The term is intended to encompass individuals sentenced
to such an institution under a criminal or civil statute, individuals detained
in other facilities by virtue of statutes or commitment procedures that
provide alternatives to criminal prosecution or incarceration in a penal
institution, and individuals detained pending arraignment, trial, or
sentencing. The University of Maine extends the term “prisoner” to
include persons on pre-trial supervised release, on community supervision
or on probation, or who is in any court-ordered deferred prosecution or
diversion program.

2.

Minimal risk is the probability and magnitude of physical or psychological
harm that is normally encountered in the daily lives, or in the routine
medical, dental, or psychological examination of healthy persons.
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D.

Composition of IRB where Prisoners are Involved
In addition to satisfying the requirements in section F. of the Administrative
Procedures for Human Subject Research, the IRB shall also meet the following
specific requirements:
1.

A majority of the IRB (exclusive of prisoner members) shall have no
association with the prison(s) involved, apart from their membership on
the IRB.

2.

At least one member of the IRB shall be a prisoner, or a prisoner
representative with appropriate background and experience to serve in that
capacity, except that where a particular research project is reviewed by
more than one IRB only one Board need satisfy this requirement.

A prisoner representative with appropriate background may include an attorney
with experience in criminal defense or prisoners’ rights, a member of a prisoners’
rights advocacy organization, a chaplain or a counselor or other similar
professional who deals, or has dealt with, prisoners.
E.

Additional Duties of the IRB where Prisoners are involved
1.

In addition to all other responsibilities prescribed for the IRB under this
part, the IRB shall review research covered by this subpart and approve
such research only if it finds that:
a.

The research under review represents one of the categories of
research permissible under 306(a)(2);

b.

Any possible advantages accruing to the prisoner through his or
her participation in the research, when compared to the general
living conditions, medical care, quality of food, amenities and
opportunity for earnings in the prison, are not of such a magnitude
that his or her ability to weigh the risks of the research against the
value of such advantages in the limited choice environment of the
prison is impaired;

c.

The risks involved in the research are commensurate with risks that
would be accepted by non-prisoner volunteers;

d.

Procedures for the selection of subjects within the prison are fair to
all prisoners and immune from arbitrary intervention by prison
authorities or prisoners. Unless the principal investigator provides
to the IRB justification in writing for following some other
procedures, control subjects must be selected randomly from the
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group of available prisoners who meet the characteristics needed
for that particular research project;

F.

e.

The information is presented in language which is understandable
to the subject population;

f.

Adequate assurance exists that parole boards, community release
supervisors, and/or probation officers will not take into account a
prisoner's participation in the research in making decisions
regarding parole, community supervision, or probation, and each
prisoner is clearly informed in advance that participation in the
research will have no effect on his or her parole, community
supervision, or probation; and

g.

Where the IRB finds there may be a need for follow-up
examination or care of participants after the end of their
participation, adequate provision has been made for such
examination or care, taking into account the varying lengths of
individual prisoners' sentences, and for informing participants of
this fact.

2.

The IRB shall carry out such other duties as may be assigned by the
Secretary of the US DHHS.

3.

The institution shall certify to the Secretary, in such form and manner as
the Secretary may require, that the duties of the IRB under this section
have been fulfilled.

Permitted Research Involving Prisoners
1.

Biomedical or behavioral research not conducted or supported by DHHS
may involve prisoners as subjects only if all of the conditions outlined
above for general human subject research, and the special conditions for
research with prisoners, are met.

2.

Biomedical or behavioral research conducted or supported by DHHS may
involve prisoners as subjects only if:
a.

The institution responsible for the conduct of the research has
certified to the Secretary that the IRB has approved the research
under 45 CFR 46.305; and

b.

In the judgment of the Secretary, the proposed research involves
solely the following:
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3.

1)

Study of the possible causes, effects, and processes of
incarceration, and of criminal behavior, provided that the
study presents no more than minimal risk and no more than
inconvenience to the subjects;

2)

Study of prisons as institutional structures or of prisoners as
incarcerated persons, provided that the study presents no
more than minimal risk and no more than inconvenience to
the subjects;

3)

Research on conditions particularly affecting prisoners as a
class (for example, vaccine trials and other research on
hepatitis, which is much more prevalent in prisons than
elsewhere; and research on social and psychological
problems, such as alcoholism, drug addiction, and sexual
assaults) provided that the study may proceed only after the
Secretary has consulted with appropriate experts including
experts in penology, medicine, and ethics, and published
notice, in the FEDERAL REGISTER, of his intent to
approve such research; or

4)

Research on practices, both innovative and accepted, which
have the intent and reasonable probability of improving the
health or well-being of the subject. In cases in which those
studies require the assignment of prisoners in a manner
consistent with protocols approved by the IRB to control
groups which may not benefit from the research, the study
may proceed only after the Secretary has consulted with
appropriate experts, including experts in penology,
medicine, and ethics, and published notice, in the
FEDERAL REGISTER, of the intent to approve such
research.

Except as provided in paragraph F.2. of this section, biomedical or
behavioral research conducted or supported by US DHHS shall not
involve prisoners as subjects.
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IV.

Additional Protections for Pregnant Women, Human Fetuses and Neonates
Involved in Research

This subpart applies to all research involving pregnant women, human fetuses, neonates,
and neonates of uncertain viability or nonviability.
The exemptions noted in section C. of Administrative Procedures for Human Subject
Research are applicable to this subpart.
This policy does not alter any present or future state or local laws or regulations that may
otherwise be applicable and which may provide additional protections for human
subjects. This subpart is intended to include the laws of federally recognized American
Indian and Alaska Native Tribal Governments.
This policy does not alter any present or future foreign laws or regulations that may
otherwise be applicable and which may provide additional protections for human
subjects.
A.

Definitions
1.

Pregnancy encompasses the period of time from implantation until
delivery. A woman shall be assumed to be pregnant if she test positive on
a pregnancy test or exhibits any of the pertinent presumptive signs of
pregnancy, such as missed menses, until the results of a pregnancy test are
negative, or until delivery.

2.

Fetus means the product of conception from implantation until delivery.

3.

Dead fetus means a fetus that exhibits neither heartbeat, spontaneous
respiratory activity, spontaneous movement of voluntary muscles, nor
pulsation of the umbilical cord.

4.

Delivery means complete separation of the fetus from the woman by
expulsion or extraction or any other means.

5.

Neonate means a newborn.

6.

Viable, as it pertains to a neonate, means being able, after delivery, to
survive (given the benefit of available medical therapy) to the point of
independently maintaining heartbeat and respiration.

7.

Nonviable neonate means a neonate after delivery that, although living, is
not viable.
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B.

Research Involving Pregnant Women or Fetuses
Pregnant women or fetuses may be involved in research if all of the following
conditions are met:
1.

Where scientifically appropriate, preclinical studies (including studies on
pregnant animals) and clinical studies (including studies on nonpregnant
women) have been conducted and provide data for assessing potential
risks to pregnant women and fetuses.

2.

The risk to the fetus is caused solely by interventions or procedures that
have the prospect of direct benefit for the woman or the fetus; or, if there
is no prospect of benefit, the risk to the fetus is not greater than minimal
and the purpose of the research is the development of important
biomedical knowledge that cannot be obtained by any other means.

3.

Any risk is the least possible for achieving the objectives of the research.

4.

If the research has the prospect of direct benefit to the pregnant woman,
the prospect of a direct benefit both to the pregnant woman and the fetus,
or no prospect of benefit for the woman nor the fetus when risk to the
fetus is not greater than minimal and the purpose of the research is the
development of important biomedical knowledge that cannot be obtained
by any other means, her consent is obtained in accord with the informed
consent provisions.

5.

If the research has the prospect of direct benefit solely to the fetus, then
the consent of the pregnant woman and the father must be obtained in
accord with the informed consent provisions, except that the father's
consent need not be obtained if he is unable to consent because of
unavailability, incompetence, or temporary incapacity or the pregnancy
resulted from rape or incest.

6.

Each individual providing consent must be fully informed regarding the
reasonably foreseeable impact of the research on the fetus or neonate.

7.

For children who are pregnant, assent and permission are obtained in
accord with the informed consent provisions for children.

8.

No inducements, monetary or otherwise, can be offered to terminate a
pregnancy.

9.

Individuals engaged in the research can have no part in any decisions as to
the timing, method, or procedures used to terminate a pregnancy.
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10.
C.

Individuals engage in the research can have no part in determining the
viability of a neonate.

Research Involving Neonates
1.

A neonate, after delivery, that has been determined to be viable may be
included in research by and in accord with the requirements described in
sections Administrative Procedures for Human Subject Research and
Additional Protections for Children Involved as Subjects in Research.

2.

Neonates of uncertain viability and nonviable neonates may be involved in
research if all of the following conditions are met:

3.

a.

Where scientifically appropriate, preclinical and clinical studies
have been conducted and provide data for assessing potential risks
to neonates.

b.

Each individual providing consent is fully informed regarding the
reasonably foreseeable impact of the research on the neonate.

c.

Individuals engaged in the research will have no part in
determining the viability of a neonate.

d.

Requirements outlined in 3. and 4. below have been met as
applicable.

Until it has been ascertained whether or not a neonate is viable, a neonate
may not be involved in research unless the following additional conditions
have been met:
a.

b.

IRB determines that:
1)

The research has the prospect of enhancing the probability
of survival of the neonate to the point of viability, and any
risk is the least possible for achieving that objective, or

2)

The purpose of the research is the development of
important biomedical knowledge that cannot be obtained
by other means, and there will be no added risk to the
neonate resulting from the research.

The legally effective informed consent of either parent of the
neonate or, if neither parent is able to consent because of
unavailability, incompetence, or temporary incapacity, the legally
effective informed consent of either parent's legally authorized
representative is obtained in accord with the section on
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Administrative Procedures for Human Subject Research, except
that the consent of the father or his legally authorized
representative need not be obtained if the pregnancy resulted from
rape or incest.
4.

D.

After delivery, nonviable neonates may not be involved in research unless
all of the following conditions are met:
a.

Vital functions of the neonate will not be artificially maintained.

b.

The research will not terminate the heartbeat or respiration of the
neonate.

c.

There will be no added risk to the neonate resulting from the
research.

d.

The purpose of the research is the development of important
biomedical knowledge that cannot be obtained by other means.

e.

The legally effective informed consent of both parents of the
neonate is obtained. However, if either parent is unable to consent
because of unavailability, incompetence, or temporary incapacity,
the informed consent of one parent of a nonviable neonate will
suffice, except that the consent of the father need not be obtained if
the pregnancy resulted from rape or incest. The consent of a legally
authorized representative of either or both of the parents of a
nonviable neonate will not suffice.

Research Involving After Delivery, the Placenta, Dead Fetus, or
Fetal Material
1.

Research involving after delivery, the placenta, dead fetus, macerated fetal
material; or cells, tissues, or organs excised from a dead fetus, must be
conducted in accord with applicable federal, state, or local laws and
regulations regarding such activities.

2.

If information associated with 1. of this section is recorded for research
purposes in a manner that living individuals can be identified, directly or
through identifiers linked to those individuals, those individuals are
considered research subjects.
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WHAT ARE THE MAJOR CHANGES IN THE REVISED COMMON RULE?
Changes to definitions:
•
•

The definition of research now excludes journalistic endeavors, oral histories and data collection
for professional non-research purposes (examples, criminal justice activities and data collection
for national security purposes).
The human subject definition is changed to include identifiable biological specimens.

Changes to Continuing Review Regulations:
•
•

•
•

As part of the new regulations, annual continuing reviews are eliminated for all new expedited
studies approved on or after January 21, 2019, unless the IRB determines that a continuing
review should be required for a specific study.
Continuing review is also not required if the research was initially approved by a convened
meeting and has progressed to the point that it involves only one or both of the following
activities:
 Data analysis (including analysis of identifiable information or identifiable biospecimens)
 Access to follow-up clinical data from procedures that subjects would undergo as part of
clinical care
Full board studies will still need annual continuing review approval.
Please note that even if a continuing review is not required modifications and reportable events
(adverse events and/or unanticipated problems) must be submitted to the IRB for review.

Changes to Consent Forms:
Long consent forms and/or consent forms for federally funded studies will require a concise summary:
•

•

The concise summary is meant to be brief. The purpose of the summary is for the participant to
decide why he/she may want to participate but should also include information on why he/she
may not want to participate in the study (for example a huge time commitment or other risks).
The summary should not include all foreseeable risks but the risks that would be most likely or
most severe to the participant.
The summary should include the following 5 elements:
1) A statement that the project is research and that it is voluntary.
2) A summary of the research (purpose, overview of procedures etc.)
3) Any foreseeable risks or discomforts
4) Any expected benefits to participants (if applicable)
5) If applicable, alternative procedures to course of treatment

You will find concise summary examples on the Forms and Samples page.
Changes to the Exempt categories:
Exempt 1 – Normal educational practices - Revised

•

The following restriction was added “not likely to adversely impact student’s opportunity to
learn required educational content, or assessment of educators who provide instruction”.

Exempt 3 Benign Behavioral Intervention – New category
•
•

•

The former exempt category 3 was eliminated and replaced with a category granting exemption
to studies involving only “benign behavioral interventions” with adult subjects. The data must
be anonymous or non-sensitive, or have sufficient protections in place to ensure data security.
Research involving benign behavioral interventions in conjunction with the collection of
information from an adult subject through verbal or written responses (including data entry) or
audiovisual recording if the subject prospectively agrees to the intervention and information
collection.
Benign behavioral interventions are defined as: “brief in duration, harmless, painless, not
physically invasive, not likely to have a significant adverse lasting impact on the subjects, and the
investigator has no reason to think the subjects will find the interventions offensive or
embarrassing.”
Examples that would fit under Category 3:
1. having subjects play an online game
2. having subjects solve puzzles under various noise conditions
3. playing economic games

•

If a study involves deception, it can be exempt under category 3 if the participants are told
during the recruitment/consent process that there is an element of deception in the study, and
they agree to participate knowing this.

Exempt 7 – Not implemented at the University of Maine at this time
•

Allows for the storage of data and/or specimens in a repository, with identifiers maintained,
that were collected under an approved IRB protocol with Broad Consent* for future secondary
use research.

Exempt 8 - Not implemented at the University of Maine at this time
•

Allows for secondary research use/analysis of identifiable data/biospecimens that were
collected under an approved IRB protocol with Broad Consent*

* Broad consent is an alternative consent process for use only for the storage, maintenance and
secondary use of identifiable private information or biospecimens for future research (yet to be
determined). See HHS Recommendations for Broad Consent Guidance for more information on broad
consent.
At this time the University of Maine (similar to many other institutions) will not use broad consent.
Changes to review of cooperative research:
•

Research conducted by investigators at multiple research sites must rely on a single IRB of
record (sIRB). However, implementation for this is January 20, 2020.

Human Subjects

Anonymous vs. Confidential
IRB Overview
When co llecting data (most often from surveys), researcher will say that the data are

Guidance & Policy
Regulations
Training
Forms and Samples
Application Deadlines
Resources

anonymous or confidential.
The two wo rds mean different things, and it is important for the participant, their
protection, and their willingness to participate that the correct term is used.

Anonymous
1. The researcher is not collecting any uniq ue identifiers from individual subjects (for
example, name, email, phone number).
2. The researcher is not collecting identifiers that, if com bined, would be likely to

!RB FAQs

identify a participant (for example, age, race, occupation, years in that occupation in
a relative ly small sample of participants).
In short, anonymous data can never be linked to an individual.

Confidential
1. Confidential data means that the researchers will be able to identify the
parti cipants. But it also means that the data w ill never be reported in a way that
allows a participant's identity to be know n (e.g., responses are combined w ith those
of other part icipan ts an d reported in aggregate form).
In short, an activity is confidential if participants provide identifying information but the
con nection
between participant and results is not shared.

Data cannot be both anonymous and confidential.
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Human Subjects
Continuin g Review Instructions
IRB Overview
In accordance w ith Federal Regulati ons, all Full Board and some expedited proj ects

Guidance & Policy
Regulations

(determined by the IRB) must undergo a continuing review. Investigators must submit a
protocol summary, a status report on the progress of the research, and current/new
consent forms. Although investigators w ill rece ive a request from the IRB Office for

Training
Forms and Samples
Application Deadlines

review in formation, it is their r esponsibility to submit r eview information in sufficient time
to allow for IRB review (at least three weeks prior to the approval expiration).
Wher e continuing review is not required. the IRB requires submission of a progress report
at periodic intervals. At the time of initial approval, the IRB will specify the interval for

Resources

!RB FAQs

submission in the approval notice. The IRB may set the interval for r eporting at one, two,
or three years. Future reporting req uirements w ill be assessed during each review and
may be changed at any time. The IRB office w ill se nd the Pl a reminder for when the
progress report is due.
Regardless of the requirement set by the I RB for r eporting study progress (continuing
review or progress r eport), investigators still must inform the IRB of any changes to the
protocol and in form the IRB of reportable events.
Please respond to the fo llowing questions: (Please type your responses on a separate

sheet of paper.)
1. Include a brief protocol summary. (This should be no more than one or two pages.)

2. Status Report Inclu des:
1. Indicate the number of subjects accrued during this reporting period and, for

ongoing stud ies, the total number accru ed.
2. Report all changes in person nel involved with the study.
3. Include a description of any: adve rse events or unanticipated problems
involvinP r isks t o <;11h iP.cts or ot hPr<;. w it h rlr;:iw;:il o f s11hiP.cts from t hP rPsP.;:irch .

o r complaints about the research.
4. Include a summary of any recent litera ture, findings obtained thus far,
amendments or modifications to the research since the last review, and any
other relevant information, especially information about risks associated with
the research.
3. Attach a copy of the current, IRB-approved informed consent docu ment (stamped
copy). Also include a "clean" copy for approval an d stamping.

Human Subjects

Data Encryption
IRB Overview
To ensure con fidentiality of identifiable, electro nic data, the Instituti onal Review Board

Guidance & Policy
Regulations

(IRS) requ ires that the electronic key linking participants' identities to their data be
encrypted. This is accom plished by the use encryption software. The IRS contacted
Information Tech nologies for advice on encryption software, and below is their response:

Training
The Information Security Office r equires as a stan dard, AES 128 or AES 256 encrypt ion for

Forms and Samples
Application Deadlines

data at rest. By far the most popular encryption software employed in the UMS is
BitLocker for Windows an d FileVau lt for Macs. Ther e isn't a cross-platfor m solution that
we are aware of.

Resources
• Windows: Bit Locker is included with Windows 8 an d 8.1 an d Windows 7 Enterpr ise

!RB FAQs

and Ultimate vers ions (it is not know n what t he cost is for other versions of
Windows 7). An open source altern ative is Diskcrytor.
• Macs: FileVault2 is included with OS X version 10.7 and higher (the only supported
versions of OS X).
• Linux: The most apparent encryption to us is Linux Uni fied Key Setup (LUKS).
There are many alternatives, including some that are not intended for full disk encryption,
but suitable for file encryption. If there is a particular alternative that would som eone
would like to discuss, contact Infor mation Technologies.

Remembe r!
• This is for ELECTRONICALLY COLLECTED/STORED IDENTIFIABLE DATA.
• If data are collected without identifiers (i.e., anonym ous data), encrypti on is not
required.
• Most often, the only data that m ust be encrypted is the computer file that is the key
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coded, but the key is in paper format (i.e., handwritten), there is nothing to encrypt
(obviously!).
• If electronic, identifiable data ar e not coded, the eritire dataset must be encrypted.
This might occur if: a) the dataset includes participants' names (usually not done),
orb) the data cou ld be identifiable because o f the type of data collected (e.g., some
demographics can identify people).
Contact the I RB Office with ~uestions about the req uirement, but contact Information
Technologies for assistance in selecting/using an encryption program.
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Institutional Review Board
Guidance for Researchers
Depression and Suicidality in Human Research
Overview
University of Maine research studies often include measures that screen for depression (e.g.,
Beck Depression Inventory (BDI), Children’s Depression Inventory (CDI), Structured Clinical
Interview). The Institutional Review Board for the Protection of Human Subjects (IRB) has
developed this guidance to assist researchers as they develop and write their human subjects
application proposing to use such measures. The IRB’s goal is to be sure that applications for
studies assessing depression and/or suicidality consistently contain information on the use of
such measures, as well as plans for follow-up with participants whose responses raise concerns
regarding level of depressive symptoms and/or intent to harm him/herself.

Adult Participants:
1.

Information to be included in an IRB application where adult participants are
anonymous:
If research is proposed where data collection will be anonymous (e.g., on-line surveys,
paper/pencil surveys):

2.

•

The summary section should name the instrument(s) to be used and why (this is not a
new requirement). If a depression measure will be used that includes a suicide item
and the researcher does not wish to include the suicide item, he/she must explain why.
The reason must be based on research goals (e.g., research goal is to assess only
depressive symptoms and not specifically suicide risks).

•

The consent form must include referrals for mental health services (following the
referral template found on the IRB website). In addition to the consent form, referrals
should repeated at the end of the survey.

Information to be included in an IRB application where adult participants’
identities are known:
•

The summary section should name the instrument(s) to be used and why (this is not a
new requirement). If a depression measure will be used that includes a suicide item
and the researcher does not wish to include the suicide item, he/she must explain why.
The reason must be based on research goals (e.g., research goal is to assess only
depressive symptoms and not specifically suicide risks).
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•

The risk section must, in addition to stating that referrals for mental health services
will be provided, describe the researcher’s plan for follow-up in situations where a
participant’s responses/score indicate a high level of depressive symptoms and/or
intent to harm him/herself.

•

The consent form (risk section) must, in addition to listing referrals in case they
become upset (following the referral template found on the IRB website), inform the
potential participant that the researcher will follow-up with them if their responses to
the questionnaires cause the researcher to be concerned for their well-being.

Instructions for follow-up:
•

In the case of follow-up for depressive symptoms, the researcher should follow-up
as soon as possible after the measures are completed. For studies done in the lab, if
the instruments could be scored quickly, a discussion could take place in the lab.
Follow-up communication via email or phone is also acceptable. The following text
may be used for the follow-up communication (in person or via email/phone):
o “I am [investigator/faculty supervisor] of the research study that you recently
completed. From your answers to the questionnaires, you seemed to be feeling
quite down. You were provided with some information about counseling
services, but I wanted to follow-up and encourage you to contact those services or
your primary care provider.” Repeat the Counseling Center information for
UMaine students and the community resources that were originally given
community participants.
o Researchers will need to be sure contact information is obtained at the start of the
study (especially critical for community participants). This could be a sentence
at the end of the consent form asking for preferred method of contact.

•

In the case of follow-up for responses indicating suicidality or imminent harm:
(regardless of the participant’s total score), the researcher must follow-up the same
day the measure is taken. For studies done in the lab, if the instruments could be
scored quickly, a discussion could take place in the lab. Follow-up communication
via email or phone is also acceptable. The following text may be used for the followup communication (in person or via email/phone):
o “I am [investigator/faculty supervisor] of the research study that you recently
completed. From your answers to the questionnaires, I am concerned that you
may harm yourself. You were provided with some information about counseling
services, but I wanted to follow-up and encourage you to contact those services or
your primary care provider.” Repeat the Counseling Center information for
UMaine students and the community resources that were originally given
community participants. If the researcher feels immediate intervention is
required, contact the Counseling Center (UMaine Students only) or Community
Health & Counseling Services has a mobile crisis team that will respond on-site.

3

o Researchers will need to be sure contact information is obtained at the start of the
study (especially critical for community participants). This could be a sentence at
the end of the consent form asking for preferred method of contact.

Minor Participants:
1.

Information to be included in an IRB application where minor participants are
anonymous:
If research is proposed where data collection will be anonymous (e.g., on-line surveys,
paper/pencil surveys):
•

The summary section should name the instrument(s) to be used and why (this is not a
new requirement). If a depression measure will be used that includes a suicide item and
the researcher does not wish to include the suicide item, he/she must explain why. The
reason must be based on research goals (e.g., research goal is to assess only depressive
symptoms and not specifically suicide risks, school district will not allow question to be
used, etc.).

• Referrals for mental health services must be provided in the consent form to
parent/guardian (following the referral template found on the IRB website).
2.

Information to be included in an IRB application where minor participants’
identities are known:
•

The summary section should name the instrument(s) to be used and why (this is not a
new requirement). If a depression measure will be used that includes a suicide item
and the researcher does not wish to include the suicide question, he/she must explain
why. The reason must be based on research goals (e.g., research goal is to assess only
depressive symptoms and not specifically suicide risks, school district will not allow
question to be used, etc.).

•

The risk section must, in addition to stating referrals for mental health services will be
provided, describe the researcher’s plan for follow-up in situations where a minor’s
responses/score indicate a high level of depressive symptoms or intent to harm
him/herself. (If the study is conducted at a school, it may be the case that
parents/guardians are informed that the guidance counselor will be informed and
he/she will follow up with them.)

•

The parental consent form (risk section) must, in addition to listing referrals in case
their son/daughter become upset (following the referral template found on the IRB
website), inform the parent/guardian that the researcher will follow-up with them if
their child’s responses to the questionnaires cause the researcher to be concerned for
his/her well-being. (If study is conducted at a school, it may be the case that
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parents/guardians are informed that the guidance counselor will be informed and
he/she will follow up with them.) The assent script should tell children that if the
researcher is concerned about how they are feeling, they will talk with their parent (or
guidance counselor).
Instructions for Follow-up:
•

In the case of follow-up for depressive symptoms. The parent/guardian is most
often the one who will be contacted with concerns. When research is conducted in
schools, it is often the case that the guidance counselor is the first point of contact.
Researchers need to check with schools to design follow-up procedures. For studies
done in the lab, if the instruments could be scored quickly, a discussion with the
parent/guardian could take place in the lab. Follow-up communication via email or
phone is also acceptable. The following text may be used for the follow-up
communication (in person or via email/phone):
o “I am [investigator/faculty supervisor] of the research study that your
son/daughter recently completed. From his/her answers to the questionnaires,
he/she seemed to be feeling quite down. You were provided with some
information about counseling services, but I wanted to follow-up and
encourage you to contact those services or your primary care provider.”
Repeat the community resources that were originally given community
participants.
o Researchers will need to be sure contact information is obtained at the start of
the study. This could be a sentence at the end of the consent form asking for
preferred method of contact.

•

In the case of follow-up for responses indicating suicidality or imminent harm.
The parent/guardian is most often the one who will be contacted with concerns.
When research is conducted in schools, it is often the case that the guidance counselor
is the first point of contact. Researchers need to check with schools to design followup procedures. For studies done in the lab, if the instruments could be scored quickly,
a discussion with the parent/guardian could take place in the lab. Follow-up
communication via email or phone is also acceptable. The following text may be
used for the follow-up communication (in person or via email/phone):
o

“I am [investigator/faculty supervisor] of the research study that your
son/daughter recently completed. From his/her answers to the questionnaires,
I am concerned that he/she may have thoughts about harming him/herself.
You were provided with some information about counseling services, but I
wanted to follow-up and encourage you to contact those services or your
primary care provider.” Repeat the community resources that were originally
given community participants.
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o Researchers will need to be sure contact information is obtained at the start of
the study. This could be a sentence at the end of the consent form asking for
preferred method of contact.

Human Subjects

Exemption Categories
IRB Overview
Guidance & Policy
Regulations
Training
Forms and Samples
Application Deadlines

It is important to remember that the investigator may not determine on his/her
own that the proposed research is exempt from furth er review. An application
must be submitted to the IRB.

Research Activities that may be Exempt from Further Review
Research involving chi ldren*, fet uses, prisoners, m entally disabled persons, or other adult
subjects of diminished autonomy is subject to special restrictions. For adult subjects of
undiminished autonomy, capable of making a truly voluntary and uncoer ced decision

Resources

whether or not to partici pate as subjects in r esear ch, the categories of research exempt

!RB FAQs

from further review requirements are:
1. Research con ducted in established or commonly accepted educational settings
involving normal educational practices, such as:
o research on regular and special education instructional st rategies; or
o research on the effective ness of or the comparison among instructional
techniq ues, curricu la, or cl assroom management meth ods
2. Research involving the use of educat ional tests (cognitive, diagnostic, apt itude,
achieveme nt) survey procedures, interview p rocedures or observation of public
behavior, unless:
o information obtained is recorded in such a manner that human subj ects can
be identified, directly or through identifiers linked to the subjects; and
o any disclosure of the human subj ect s' responses outside the r esearch could
reason ably place the subjects at risk of criminal or civil liability or be damaging
to the subjects financial standing, employability, or reputation .
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responses, (including data entry or audiovisual r ecording) from adult subjects who
prospectively agrees and ONE of the following met:
o Recorded information cannot readily id entify the subject (directly or
indirectly/ Ii n ked);
o Any disclosure of responses outside of research would NOT rea son ably place
subject at risk (criminal, liability, financial, employability, educational
advancement, reputation); OR
o The information obtained is recorded by the investigator in such a manner that
the ident ity of t he human subjects can rea dily ascertained, directly or ind irectly
through identifiers linked to the subjects, and an IRB conducts a limited IRB
review to make the determination req u ired.
4. Research involving the collection or study of existing data, documents, r ecords,
pathologica l specimens, or diagnosti c specim ens if these sources are publicly
available or if the information is recorded by the investigator in such a manner that
subjects cannot be identi fied, directly or through identifiers linked to the subjects.
5. Research an d demonstration proj ects w hich are co nducted by or subject to the
approval of department or agency heads, and which are designed t o study, evaluate,
or otherwise examine:
o public benefit or service progra ms;
o procedures for obtaining benefits or services under those programs;
o possible ch anges in or alternatives to those programs or procedures; or
o possible ch anges in methods or level s o f paym ent for benefits or services
under thos e programs.
6. Taste and food quality evaluation and cons um er acceptance studies:
o if w holesome foods without additives are consumed; or
o if a fo od is consumed that contains a food ingredient at or below the level and
for a use foun d to be safe, or agricultural chemical or environmental
contaminant at or below the level fou nd to be safe, by t he Food an d Drug
Administration or approved by the Environmental Protection Agency or the
Food Safety and Inspection Service of the U.S. Department of Agriculture.

•when the humon subjects are children, only five of the above cat egories apply. Exemption 2 (for research involving
survey or interview procedures or observations of public behavior), does not apply to research with children, except
for research involving observation of public behavior when the investigator(s) do not participate in the activities
being observed.

n

IDlUII

f

D

@)

~

Apply

Student Resources

Nondiscrimination notice

Clery Safety and Secunty Report

COVID-19 health and safety guidance

Emergency

University of Maine

m

Human Subjects
FERPA Guidance
IRB Overview
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Considerations When Collecting Student Records
When co llecting education records from students (K-12 and higher education) The Fam ilY.
Educational Rights and Pr ivacY. Act (FERPA) and the Protection of PuP-ils Rights

Training
Forms and Samples
Application Deadlines

Amend ment (PPRA) are two laws that must be taken into consideration.
FERPA (34 CFR Part 99) is a Federal law that protects the privacy of student education
records. The law applies to all schools that receive fun ds under an applicab le program of
the U.S. Department of Education. It is t he invest igator's responsibility to be aware of

Resources
!RB FAQs

when these laws wo uld affect their research and to be aware of his/her obligations
with the school.
PPRA (20 U.S. Code § 1232h) is a federa l law that affords certain rights to parents of m inor
students with regard to surveys t hat ask questions of a personal natur e.

FERPA
Generally, schools m ust have written perm ission from the parent or eligible student in
order to release any infor mation from a student's education record.
Exceptions to FERPA
1. FERPA allows schools to d isclose those records, w ithout consent, to the following
part ies or under t he
following conditions:
o School officials with legitimate educational interest;
o Other schools to which a student is transferr ing;

o Speci fied offi cials for audit or evaluation purposes;
o Appropriate parties in connection with f inancial aid to a student;
o Accrediting organizations;
o To comply with a jud icial order or lawfu lly issued subpoena;
o Appropriate offic ials in cases of health and safety emergencies; and
o State and local authorities, within a juvenile j ustice system, pursuant to specifi c
State law
o Organizations conducting certain studies for or on behalf of the school.
2. Schools may discl ose, w ithout consent, "directory" information such as a student's
name, address, telephone number, date and place of birth, honors and awards, and dates
of attendance. However, schools must tell par ents and eligible st udents about directory
information and allow parents and eligible stu dents a reasonable amount of time to
request that the school not disclose directory information about them.
Resea rchers should contact each educational institution from w hich he/she
proposes to access student records and follow that institution's FERPA policy and
procedures when accessing and proposing to disclose any directory information.

3. Schools may disclose information from student education records without prior
consent if all personally identifiable information has been removed from the records,
provided that the institution has made a reaso nable determination that a student's
identity wou ld not be personally identifiable, w hether through single or multiple releases,
and taking into account other reasonably available information.
Note that it is t he educational institution t hat holds the student records that has to
make t his determ ination.

PPRA
The PPRA applies to the programs and activities of a State educational agency (SEA), loca l
educational agency (LEA), or other recipient of fun ds under any program funded by t he
U.S. Department of Education. It governs the administration to students of a survey,
analysis, or eva luation that concerns one or mor e of the following eight protected areas:
• politica l affi liations or beliefs of the student or the student's parent;
• mental or psychological problems of the student or the student's family;
• sex behavior or attitudes;
• illegal, anti-social, self-incrim inating, or demeaning behavior;
• critical appraisals of other individuals with whom respondents have close family
relationships;
• legally recognized privileged or analogous relationships, such as those of lawyers,
physicians, and
ministers;
• religious practices, affiliations, or beliefs of the student or student's par ent; or,
• income (other than t hat required by law to determine eligibility for participation in a
program or
for receiving financial assistance under such program).
Resea rchers whose research is subj ect to t he PPRA should review t he policies of t he
local educational
agency ear ly in the study design process.
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Guidelines for Class Projects Involving Human
Subjects
These guidelines are intended to assist instructors in determining when class projects
meet the definition of research w ith human subjects and requ ire review by the University
of Maine's Institutional Review Board for the Protectio n of Human Subjects (i.e., IRB).

Training
For questions or additional guidance, contact the IRB Office.

Forms and Samples
Application Deadlines
Resources
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For clarification, the following are NOT class projects; if they involve human
subjects, they are considered research and must be reviewed and approved by the
IRB:

• Senior research proj ects conducted within the framework of the senior capstone
experience
• Honors theses
• Master's theses
• Doctoral dissertations

• Instructors should meet with students as soon as possible and go over these

guidelines to determine if the proposed class project could be considered research.
• If there is even a remote possibility that a class project may fall under the defin ition
of resea rch, instructors are advised to submi t a human subjects review applicati on
with the student to the IRB. Rememb er, class projects that involve protected
populations, collection of sensitive information, or entities covered by another
IRB, e.g., EMMC, Penobscot Nation (as defined at the end of this document)
requ ire IRB review and approval.
If the class project meets the definition of research:

The instructor should meet w ith the student to prepare t he human subjects review
application.
• If the project goes before t he Full Board at its monthly meeting, the instructor must
attend the IRB meeting w ith the student.
A

If t he cl ass proj ect does not meet the definition of research

TOP

Review Procedures
• Class projects t hat involve systematic collection of data and for w hich the design or
obj ective is to develop or contribute to generalizable knowledge are considered
research. In other words, if the student (or instructor) plans to use the data outs ide
of t he class, the project is considered research and requires IRS review.
• Marketing studies - if students collect data for a company or entity (e.g., r estaurant)
as part of a class marketing project, IRB r eview would NOT be required as long as
these t hr ee conditions are met:
■ Students are simply giving the co llected data to the company, and

the data are for the com pany's internal use only (e.g., the data will
not be presented in a public forum).
■ Students have no plans to use t he data for an honors thesis,

research presentation at co11ferences, master's thesis, or
d issertation.
■ The project does NOT involve protected populations, collection of

sensit ive information, or involve entities covered by another IRB,
e.g., EM MC, Penobscot Natio n (as defined at the end of this
document).
• Class projects that are designed solely with the objective of providing students with
training about and experience with research methods are not considered research.
In cases in w hich data will not be used outs ide of the cl assroom context and data
will be dest royed upon completion of t he project, these proj ects are not
considered research and do not req uire IRS review. HOWEVER, if the instructor
allows a student to design a class proj ect t hat involves protected populations,
collection of sensit ive informat ion, or entit ies covered by another IRS, e.g.,
EMMC, Penobscot Nation (as defined at the end of this document), IRS review
and approval are requ ired.

Training Requirements
Instructors assigning class projects are required to comp lete the IRB training tutorial.
• Instructors should require students to com plete the IRB training tutorial as part of
the learning experience, even in cases when the stu dent's proj ect does not have to
obtain IRB approval.

Instructors' Responsibilities
• Instructors should meet with students as soon as possible and go over these
guidelines to determ ine if the proposed class project co uld be considered research.
• If there is even a remote possibility that a class project may fall under the defin ition
of research, instructors are advised to submit a human subjects review application
with t he student to the IRB. Remember, class proj ects t hat involve protected
populations, collection of sensitive information, or ent ities covered by another
IRS, e.g., EMMC, Penobscot Nation (as defined at the end of this document)

require IRB review and approval.
If the class project meets the definition of research:
The instructor should meet w ith the student to prepare the human subjects review
applicati on.
• If the project goes before the Full Board at its monthly meeting, the instr uctor must
attend the IRB m eeting w ith the student.

If the class project does not meet the defi nition of research
• It is the r esponsibility of the instr uctor to ensure that the stu dent project does not
meet the definition of research.
• It is the r esponsibility of the instr uctor to ensure that the class proj ect is con ducted
according to the ethical standards of the relevant discipline.
• Remember that from the participant's viewpo int, giving out personal information
does not differ for a class assignment or a research project. Personal infor mation is
personal infor mation. Instructors sho uld adv ise stu dents to identify the proj ect to
parti cipants as a class assignment an d be sensitive to the personal nature of the
obtained informati on. Labeling the class project as "research" is inaccurat e and
m isleading to participants.
• Students should inform participants that data will be destroyed after their
assignment or class project is completed (end of the semester).
• Inst ructors are advised to tell stu dents that d ata from human subjects should not
contain any personal, identifying infor mation whenever possible.
• All class projects must include informed consent language that closely fo llows the
guidelines. Infor m ation on what to include i11 a consent form/script is described
below. For an on-line survey, th is would be th e first page of the survey or in the
email post.
• The IRB is available to give feedback on any p roposed class proj ect not meeting the
definition of r esearch, even though the IRB would not officially act on the project.

Any class proj ect that m eets the definition of research or involves protected populations,
collection of sensitive infor mation, or involves entities cover ed by another IRB, e.g.,
EMMC, Penobsoct Nation m ust be reviewed and approved by the IRB (co ntact the IRS
Office). Approval cannot be granted retroactively under any circumstances for any

research project.

We would like to acknowledge the use of /RB guidelines on class-related projects from both
Pennsylvania State University and Duke University.
Information to Include in Email Postings or Verbal Script s for Informed Consent
When infor mation is collected for a cl ass project that does not meet the definition of
research (a s defi ned by the federal r egulations) and does not require approval by the IRB,

it is still important to "inform" the participants about the class project, whether posted as
an email message or presented verbally in person . Make sure the participant is told:
• The identity of t he student (introduce yourself!). (This may not always be necessary,
as many students enlist the help of friends or family to collect data for a cl ass
project.)
• They must be at least 18 years of age to participat e.
• It is a class proj ect. (Give a little infor mation, e.g., This is for my business class, I am
t rying to see if there is a relationship between X an d Y.)

• What they will be asked to do ("I would like to ask you some questions about why
you chose to attend the University of Maine. If there are any questions you don't
want to answer, it is fi ne to skip them.").
• How long the interview, survey, etc., may take to complete.
• What w ill happen to the information collected ("The information w ill be used to write
my paper for the class, an d I will give a presentation in class. All of my notes,
surveys, etc., will be destroyed when the sem ester is over.")
• If they w ill be identified: examples: "I will not write your name on my notes"; "Do not
write your name on the survey;" "I will not use you r name in my paper."
• The student's and instructor's contact inform ation if they have any questions
(provide phon e number/email).
Here is an example of a posting for a survey: NOTE: If yo u use Qualtrics,

SurveyMonkey, etc., the consent information shoUJld also be the first page of the survey.
This survey is for a class research project in (Course #/Name.) Our names ar e XXXXX. We
are conducti ng a survey about XXX fo r a r eport and a class presentation.
Participation: You need to be at least 18 to participate. Participation is voluntary. You can
stop the survey at any time or skip questions. The survey should take only about 10
minutes to complete.
Risks: Risks for participating are minor- just your t ime.
Confide ntiality: We are not co llecting any names, so the survey is anonym ous.
Presentation: We are going to use the information for a class presentation and then
d estroy survey data.
Contact Info rmat ion: Please contact us if you have any questions: names/emails
Instructor: name an d contact information)

Protected Population s/Sensitive lnformat1on/Oth er Except10ns
* Protected Populations - Examples inclu de, but are not limited to:
• Children/M inors (under the age of 18) (Exception - projects conducted in
estab lished or com monly accepted educational settings involving normal
educational practices. Contact IRB office for guidance.)
• Prison ers (now includes non-publicly available secondary data)
• Pr egnant women
• Fetuses and products of labor an d delivery
• People with diminished capaci ty to give consent
• Menta lly or physically challenged individuals
*Sensitive Information - Exam ples inclu de, but are not limited to :
• Information relating to an individual's psycho logical well being or mental health

• Information relating to sexual attitudes, preferences, or practices
• Information relating to the use of alcohol or drugs
• Information relating to illegal behavior
• Information that if released could r easonably place the individual at risk of criminal
or civil liability or be damaging to the individual's financial stan ding, employability, or
reputation
• Information that wou ld normally be recorded in a patient's medical record and the
d iscl osure co uld reasonably lead to discriminati on, stigmatization, etc.

* Other:
• Be awar e that ther e could be instances w her e a class project cou ld fall under the
authority of another I RB such that these guidelines would not apply, e.g., studies
proposed to involve Eastern Maine Medical Center (EMMC) staff or patients,
members/citizens of t he Penobscot Nation (specifically targeted).
* Instructors/students who are unsure of whether a proposed project involves a protected
population or sensitive information should co ntact the IRB Office.
Flow Chart for Guidance on Whether a Class Project Renu ires IRB Review (PDF)

Is t he project a senior capstone
project, honors thesis, masters
t hesis, or doctoral dissertation?

Is t he project solely for a class
assignment w here data will not
be used outside of t he c lassroom
context and data are destroyed
at t he end of t he project w it h no
f urther use?

~

_ I_R_B_R_e_v_
i e_w_R
_e_q_u_ir_e_d____,

._I

~ ._r

_ IR_B_R
_e_v_ie_w_R
_e_q_u_ir_
ed_~

~ ~I__M_ ar_k_et_in_g_S_tu_d_y_?_ ~
◊
M arketingStudy(studentscollectingdata for a businessl:
(11Students are simply givingthecollected d ata to the
business, and the dataarefor the business's internal use only
(e.g., t he dot.will not be present ed in a public forum).
(2) Students hiM! no plans to US1!th<!datator an honors thesis,
research presentationatconferences, master's thesis, or
dissertation.
(3) The project does NOT involve protected populations or
sensitive information (asdefined at the end of this document).

All 3 conditions met,
IRB review NOT required

Does t he project involve
protected populations, collection
of sensitive information, or

entitles covered by another IRS,
e.g., EMMC, Penobscot Nation?
(See examples on next page.)

Any of t he 3 conditions not
met, IRB review required

~ [ IRB Review NOT Required

~[

IRB Review Required

Examples of Protected Populations/Sensitive Areas/Other Exceptions
Protected Populations – Examples include, but are not limited to:
•

Children/Minors (under the age of 18) (Exception – projects conducted in established or
commonly accepted educational settings involving normal educational practices. Contact IRB
office for guidance.)

•
•
•
•
•

Prisoners (now includes non-publicly available secondary data)
Pregnant women
Fetuses and products of labor and delivery
People with diminished capacity to give consent
Mentally or physically challenged individuals

Sensitive Information – Examples include, but are not limited to:
•
•
•
•
•
•

Information relating to an individual’s psychological well-being or mental health
Information relating to sexual attitudes, preferences, or practices
Information relating to the use of alcohol or drugs
Information relating to illegal behavior
Information that if released could reasonably place the individual at risk of criminal or civil liability
or be damaging to the individual’s financial standing, employability, or reputation
Information that would normally be recorded in a patient’s medical record and the disclosure
could reasonably lead to discrimination, stigmatization, etc.

Other –

•

Be aware that there could be instances where a class project could fall under the authority of
another IRB such that these guidelines would not apply – e.g., studies proposed to involve
Eastern Maine Medical Center (EMMC) staff or patients, members/citizens of the Penobscot
Nation (specifically targeted).

Instructors/students who are unsure of whether a proposed project meets the guidelines for class
projects should contact the IRB Office at 1-2657, email: umric@maine.edu. Remember, the IRB will not
conduct retroactive reviews, so ask questions early and plan early! Conducting research with human
subjects without IRB approval is a violation of the University’s Policy on the Protection of Human Subjects.

September 2018

Department of Civil and
Environmental Engineering

PER GÅRDER, PH.D., P.E.
302 Boardman Hall
University of Maine
Orono, ME 04469-5711
Telephone 1 207 581 2177
E-mail address: Garder@Maine.edu

www.umeciv.maine.edu

CIE 424

URBAN TRANSPORTATION PLANNING

SPRING 2010

Instructor:

Per Gårder, contact me by First Class or e-mail Garder@Maine.edu or, if important, cell phone
852-8268. Open door office policy
Text:
Urban Transportation Planning, Second Edition by Michael D. Meyer & Eric J. Miller. Publisher:
McGraw-Hill, Inc. ©: 2001
Objectives: To teach students basic concepts and practices in the field of transportation planning, including
the process and policy surrounding urban transportation planning.
Catalog Description: Basic concepts and practices in the field of transportation planning, including the process
and policy surrounding urban transportation planning, characteristics of urban travel, air quality, noise, energy,
land use, the elements of decision making, data management and diagnosis, demand and supply analysis, project
evaluation and implementation. A transportation demand management study constitutes a major part of the
course. (2.0 ED/1.0 ES) Lec. 3. Prerequisites & Notes: CIE 225. Credits: 3
Expected Course-Specific Outcomes:
The student will:
1. understand basic terminology used by transportation planners
2. have a basic understanding of some of the history behind today’s transportation planning
3. understand how automobile traffic influences safety, mobility, environment, and financing
4. understand how trips are generated, distributed and assigned to modes and routes
5. acquire an understanding of professional and ethical responsibility
6. acquire a knowledge of contemporary transportation-planning issues
7. acquire an understanding of the impact of engineering solutions in a global and societal context
8. acquire an ability to identify, formulate, and solve transportation planning problems
9. acquire an ability to design and conduct experiments, as well as to analyze and interpret data
10. acquire an ability to design a system, component, or process to meet desired needs, such as maximum
allowed noise levels.
General Information:
1. Good attendance is encouraged since the tests will include questions not only on the textbook but also
additional material covered during the lectures. Quizzes may appear without any notice!
2
A project will be completed. The project will be worked on in groups of 2 - 4 students. The objective
of the project will be decided on together with the students. It is recommended that this year, the
projects should deal with issues relating to the City of Bangor’s next comprehensive plan (due during
2010). Should Bangor’s transportation systems be ‘nudged’ in a specific direction or should marketforces rule? What about bicycling? Public transportation? Connections to other regions, etc. But the
project could also be to do a Travel Demand Management Study for a smaller urbanized area; or to look
at noise concerns in…. or…. The work should typically include detailed structuring and scheduling of
the study, formulation of hypotheses to be tested, observational field studies, making up and administering interviews and questionnaires, the writing of a report, and presentations of the findings to the class
and possibly to invited professionals. Survey forms must be discussed in class before they are administered. If a project includes a survey, or other direct interaction with people, make sure that:
a) You approach people over the age of 18 only
b) You identify the project to participants as a class assignment, not as university research
c) You inform participants that data will be destroyed after their assignment or class project is completed
Syllabus CIE 424 Page 1

d) The data does not contain any personal, identifying information whenever possible
e) The project includes informed consent language. For an on-line survey, this would be the first page of
the survey or in the email post. Make sure the participant is told:
- about the identity of the investigating student(s) (introduce yourself)
- that this is a class project. (Give a little information, e.g., This is for my … class, I am trying to study…)
- what they will be asked to do (“I would like to ask you some questions about why you …. If there are
any questions you don’t want to answer, it is fine to skip them.”)
- how long the interview, survey, etc., may take to complete
- what will happen to the information collected (“The information will be used to write my paper for the
class, and I may give a presentation in class. All of my notes, surveys, etc., will be destroyed …”)
- if they will be identified. Examples: “I will not write your name on my notes”; “Do not write your
name on the survey;” “I will not use your name in my paper.”
- the student’s and instructor’s contact information if they have any questions (provide phone number/email).
f) Protected Populations. Do not approach these groups. Examples include, but are not limited to: Children/Minors (under the age of 18), prisoners (now includes non-publicly available secondary data), pregnant women, fetuses and products of labor and delivery, people with diminished capacity to give consent, mentally or physically challenged individuals.
g) Sensitive Information that you cannot include – Examples include, but are not limited to: Information
relating to an individual’s psychological well being or mental health; information relating to sexual attitudes, preferences, or practices; information relating to the use of alcohol or drugs; information relating
to illegal behavior, information that if released could reasonably place the individual at risk of criminal
or civil liability or be damaging to the individual’s financial standing, employability, or reputation; information that would normally be recorded in a patient’s medical record and the disclosure could reasonably lead to discrimination, stigmatization, etc.
3. Homework problems will be assigned but not collected or graded. Test questions will sometimes be similar to assigned homework.
4. Students are expected to be present during times assigned to the project and for all tests. Make-up tests
will be given only for authorized medical reasons.
5. All computations and steps should be shown for all exams, whenever requested. Some tests may be of
multiple-choice type.
6. Civil Engineering students must adhere to the University of Maine Conduct Code. Each student is expected to work independently on all exams, including take home exams. Students may neither give nor
receive assistance on examinations. All written material, including term papers, reports, etc., must be the
student's original work. The bounds of original work and the degree of collaboration that will be allowed
in this class will be established by the professor. The work(s) of others may only be used with proper reference or acknowledgement. Failure to adhere to this policy can result in the receipt of a failing grade,
suspension or dismissal from the University. Group interaction is generally necessary for laboratory data
gathering and is encouraged but not necessary for data reduction.
7 Accommodations for students with disabilities: If you have a disability for which you may be requesting
an accommodation, please contact either me or Ann Smith, Coordinator of Services for Students with
Disabilities (Onward Building, 581-2319), as early as possible in the term.
8. No tuition refund will be allowed if course dropped later than second week of classes-unless very extraordinarily extenuating circumstances exist.
9. Examinations:
Test 1 15%
Quizzes 2% each
Main Project 20%
Test 2 15%
Mini-project 1/2 5%
Final exam 20%
Test 3 15%
Newspaper 3%
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10. Grades:

11.

90% and above
87.5-89.99%
85-87.49%
80-84.99%
77.5-79.99%
75-77.49%

70-74.99%
67.5-69.99%
65-67.49%
60-64.99%
Below 60%

A
AB+
B
BC+

C
CD+
D
E

SCHEDULE CIE 424: Tuesdays and Thursdays 8:00-9:15 in 130 Barrows Hall

Jan. 12 Introduction and consensus exercise
14 Rethinking Urban Sprawl. Andres Duane,
video.
19 Chapter 1 & notes. Mini-project: Travel
Diary Mini-project 1 and 2 assigned
21 Continued Chapter 1 and notes
26 Transportation Planning and DecisionMaking, Question 7 (page 83) assigned +
Mini-project assignment: Review BDN
for two weeks ‘environment’ and ‘transportation’
28 Transportation Systems, Chapter 3.
Project. Finalizing overall objectives and
group belongings.
Feb 2 Air Quality
4 Noise (Chapters 3, 7). Assignment
9 Energy-Land use (Chapters 3, 7)
11 Characteristics of Urban Travel
16 Safety, Travel costs, Chapter 3
18 Test 1
23 Data Management and Use, Chapter 4.
Question 4 (page 239) assigned
25 Demand Analysis, Chapter 5 and Projectpresentation of group objectives, draft
outlines and discussion on surveying
techniques
Mar 16 Trend analysis, Elasticity models Homework. Chapter 5.
18 Minimum path—equilibrium Assignment.
23 Gravity model, Chapter 5, Modified
Question 6 (page 322) take-home quiz
assignment
25 Logit model, Chapter 5. Questions 8 & 9

(page 324) assigned
30 Test 2
Apr 1 Urban Activity Systems. Chapter 6.
Question 5 (page 377) assigned
6 continued Chapter 6
8 Supply Analysis (fundamental eq.),
Chapter 7 Time-distance diagrams,
queuing theory. Questions 1, 2, and 3
(page 474) assigned Transit/walking,
Question 5 (page 476) assigned
13 Cost models, Chapter 7
15 Transportation System and Project Evaluation, Chapter 8. Question 4 & 6 (page
558) assigned
20 Program and Project Implementation,
Chapter 9
22 Test 3
27 Project presentations
29 Traffic calming or SL. Class evaluation
May 3-7 Final Exam (open book)
Note: The above schedule and procedures in this
course are subject to change in the event
of extenuating circumstances. In the event
of disruption of normal classroom activities due to an H1N1 swine flu outbreak,
the format for this course may be modified
to enable completion of the course. In that
event, you will be provided an addendum
to this syllabus that will supersede this
version.
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Human Subjects

Human Subject Payment Guidelines
IRB Overview
1. University of Maine r esearchers may provide cash (or cash equivalents [incentives],

Guidance & Policy
Regulations
Training

including gift cards, meal money, apparel, etc.) to h uman subjects if the protocol has been
approved by the Institutional Review Board (IRB).
2. It is the responsibility of the researcher (not the IRB, Office of Research Adm inistrat ion,
or the Office of the Vice President for Research and Dean of the Graduate School) to

Forms and Samples
Application Deadlines
Resources

make appropriate funding arrangements.
3. If the approved I RB protocol assures the confidentiality of human subj ects, r esearchers
will maintain the following data* , as speci fied in the I RB -approved protocol, in a secur e
project file:

!RB FAQs
• Subject name
• Subject address
• Date the payment was provided
• Va lue or amount of the payment
• Form of the payment
• Name of researcher providing the payment
• Peoplesoft chartfield combination
• UMS employee status of the subject (UMS employee or non -employee).
4. If the University of Maine is subj ect to an audit, r esearchers may be requ ired to provide
audito rs access to confidential data.
5. If the va lue of a one-time payment exceeds $75.00, subject data must be reported to
other offices within the University of Maine and Univer sity of Maine System, as follows:
• If the human subject is an employee of the University of Maine, the researcher must
........... ,,.....+ .........

,.-.,,-h ........., , ....... ,,.. ........ .- .,.,..., +h .... r-. ......................... ............. ,,..,fu , , ................ n .... ,..,,... ,,,...,.. .... ,.. T h .... r-. ........ ........................... ...
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tJd Y I I I te l Jl::, lV t i I t:' Lltcp c:u U I l t::I Ill U I I I U I I ld l I f\ tc:>UUI Lt:':>, I I I t:' Llt::tJc:tl U I I ICI It

of Human Resources will determine whether the value of the reported incentive
needs to be added to the employee's gross wages, and whether the payment w ill be
subject to taxation and withholding.
• If the human subj ect is not an employee of the University of Maine, the researcher
shall report any such payments to Michae l Noblet in the Department of Purchas ing.
The researcher will work with t he Department of Purchasing to com ply with IRS
regulations that require the University of Ma'ine System to issue a Form 1099 wh en
cumu lative payments to a non-employee reach $600 in a calendar year.
* If the subj ects ar e minors, contact the IRB office for furt her guidance.

Guidelines last revised 09/29/2015.
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Human Subjects
Information About Oral History Activities
IRB Overview
Recently, representatives from the Office of Human Research Protection (OHRP) and the

Guidance & Policy
Regulations

Oral History Association engaged in a dialog about whether oral history interviewing
activities meet the OHRP's definition of research. Accord ing to OHRP. oral history
interviewing activities, in general, are not designed to contribute to generalizable

Training
Forms and Samples

knowledge and do not meet the definition of resea rch offered by the Department of
Health and Human Services. The Univers ity of Maine's IRB recognizes this and concu rs
that the majority of oral history interviewing projects pro bably do not constitute research.

Application Deadlines
However, some ora l history interviewing projects may meet the definition of research.

Resources
!RB FAQs

Thus, it would be difficult and misleading to adopt a policy for any type of activities by any
department, group, or individuals under a particular head ing (e.g., oral history
interviewing projects) that unequivocally states that the activity does not meet the
definit ion of r esearch and does not require r eview by the IRB. The IRB realizes that
individuals may construe our position on this issue as ambiguous. The IRB, however,
needs to make decisions about projects on a case by case basis. Thus, we ca nnot adopt a
policy that directly states that all or al histo ry interviewing activities are not considered
research. We offer the following informat ion that might be helpful in determining when a
project is considered to be or not to be research.
To assist individuals in determining when/ if oral history act ivit ies r equire human subjects
review. we have provided the fo llowing information from Michael Carome (OHRP). (This
information repr esents a r esponse to Northern Illi nois University's r equest for
clarification regarding oral histo ry projects.)
The University of Maine's IRB found this information to be helpful. As University of Maine
employees, students, and agents read this and see statements such as, "Unless such
research is exem pt under HHS regu lations at 45 CFR 46.1 0 1(b) ..." remember that it is

UMaine policy (as it is at most institutions) that someone OTHER than the investigator
must deter m ine if a proj ect fits one of the six categories judged exempt from further
review. "Exempt" does not mean a review is NOT required .
More for mal guidance is expected from OHRP, so we will post additional information
wh en/ if it is available.
Listed below are the examples provided to assist in deter mining w hen a r eview might be
requ ired .
"As you are aware, representatives of oral history organizations earlier this year asked
OHRP to review a policy statement that they had d rafted regarding the r elationship
between research (as defined by the Departm ent of Health and Human Services (HHS)
regu lations at 45 CFR 46.102(d)) an d oral history activities. They also asked whethe r OHRP
agr eed with the content of their draft policy.
OHRP responded to the oral histor ians w ith a letter stating OHRP's concurrence with the
draft policy statement that oral history activities in general do not involve research as
defined by the HHS regulations and providing some suggested edits. I have attached a pdf
file containing a copy of OHRP's letter below. Please note that the inclusion of t he words
"in general" in OHRP's response means that certain human subjects resea rch activities
may include oral history activities, an d such research activities should be reviewed by an
institutional review board (IRB) unless the r esearch is exempt under HHS regulations at 45
CFR 46.101(b). I
Indeed, in its September 22 letter, OHRP noted that on occasion, investiga tors conducting
human subjects r esearch as defined by the HHS regulations may use oral history
interviewing procedures. Unless such research is exempt under HHS regulations at 45 CFR
46.101(b), IRB review would be required if the research is conducted or supported by HHS
or conducted under an appli cable OHRP-approved assurance.

History
Issues regarding oral history an d human subjects research date back to the National
Commission and most recently emerged with NBAC, NHRPAC. an d a letter from oral
historians to OHRP.

The Regulatory Definition of Research
A decision whether oral history or other activities solely consisting of open ended
q ualitative type interviews are subject to the policies and regulations outlined in an
institution's FWA and HHS regu lations for the protection of human research subj ects (45
CFR 46) is based on the prospective intent of the investigator and the definition of
"research" under HHS regu lations at 45 CFR 46.102(d): "a systematic investigation,
including resea rch development, testing and evaluation, designed to develop or
contribute to generalizable knowledge."
Specifically, for the purposes of Olff discussion, the evaluation of such activities hinges
upon whether the person is engaged in the creat ion of "generalizable knowledge" that is,
whether the activity represents a systematic invest igation in which the person engaged in
such activities intends to develop or contr ibute to generalizable knowledge. However, 45
CFR 46 does not provide a definition of "generalizable knowledge". Oral history activities,
as described to OHRP by the oral history representatives, in general are designed to
create a record of specific histor ical events and, as such, are not intended to contribute to
generalizable knowledge.

General principles for evaluating Oral History type activities
1. Oral history activities, such as ope n ended in terviews, that ONLY document a
spec ific historical event or the expe rie nces of ind ividuals w ithout an intent to draw
conclusions or generalize fin dings would NOT constitut e "research" as define d by
HHS regulations 45 CFR part 46.
o Exam ple: An oral history video r ecording of interviews with holocaust survivors
is created for viewing in the Holocaust Museum. The ueation of t he video tape
does NOT intend to draw conclus ions, inform policy, or generalize fi nd ings. The
sole purpose is to create a historical record of specific personal events and
experiences related to the Ho loca ust and provide a venue fo r Holocaust
survivors to te ll their stories.
2. Systematic investigations involving open-ended interviews that are designed to
develop or contribute to generalizable knowledge (e.g. , designed to draw
conclusions, infor m policy, or generalize find ings) WOULD constitute "research" as
defi ned by HH S regu lations at 45 CFR part 46.
o Exam ple: An open ended interview of su rviving Gu lf War veterans to doc ument
their experiences and to draw conclusions about their experiences, inform
policy, or generalize fin dings.
3. Oral historians and qualitative investigators may want to create arch ives for the
pur pose of providing a resource for others to do research. Since the intent of t he
archive is to create a repository of information for other investigators to cond uct
research as defined by 45 CFR part 46, t he creation of such an archive WOULD
constit ute research under 45 CFR pa rt 46.
o Examp le: Open ended interviews are conducted with surviving Negro League
Baseball players in order to creat e an archive for future research. The creation
of such an archive would constitute research under 45 CFR part 46 since the
intent is to collect data fo r future research.
An institution shou ld perfor m an initial two step evaluation prior to deciding whether an
activity constitutes human subject research:
• dete rmine whether the activity constit utes "research" as defined by 45 CFR
46.1 02( d); and
• deter mine whether the "research" inc ludes h uman subjects as define d by 45 CFR
46.102(f).
In summa ry, the August 26, 2003 Policy Statement attached to OHRP's September 22,
2003 letter was not drafted by OHRP, does not cons titute OHRP gu idance, an d the
character izations of oral history activities in the th ird paragraph of the Policy Statement
alone do not provide suffic ient bas is fo r OHRP's determination t hat oral history activities
in general do not involve research as defined by HHS regulations at 45 CFR part 46. Other
activities involving open-ended interview that have similar characteristics can involve
research as defined by the HHS regu lations when t he activities are part of a systematic
investigation designed to develop or cont ribute to genera li zab le knowledge."

We hope that the above information may be helpful to ind ividuals who engage in oral
history interviewing activities. If an ind ividual has any question as to whether his or her
proj ect could be considered research, please contact the IRB office.
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Informed Consent

Except where specifically waived or altered by the IRB under Section I.K.3-4 of the
University of Maine’s Policies and Procedures for the Protection of Human Subjects of
Research, all human subjects research will require written informed consent. For projects
exempt from further review, documentation (signature) of informed consent is not required,
but the same basic elements of an informed consent should be applied. The following two
paragraphs were taken from the Office for Human Research Protections (NIH) website on
the protection of human subjects of research.
“Informed consent is a process, not just a form. Information must be presented to
enable persons to voluntarily decide whether or not to participate as a research subject. It is
a fundamental mechanism to ensure respect for persons through provision of thoughtful
consent for a voluntary act. The procedures used in obtaining informed consent should be
designed to educate the subject population in terms that they can understand. Therefore,
informed consent language and its documentation (especially explanation of the study's
purpose, duration, experimental procedures, alternatives, risks, and benefits) must be
written in "lay language", (i.e. understandable to the people being asked to participate). The
written presentation of information is used to document the basis for consent and for the
subjects' future reference. The consent document should be revised when deficiencies are
noted or when additional information will improve the consent process.”
“Use of the first person (e.g., "I understand that ...") can be interpreted as
suggestive, may be relied upon as a substitute for sufficient factual information, and can
constitute coercive influence over a subject. Use of scientific jargon and legalese is not
appropriate. Think of the document primarily as a teaching tool not as a legal
instrument.”
NOTE: For studies requiring continuing review, approval information (with expiration
date) will be added to the approved informed consent document; that version will be
provided to the researcher and must be used in obtaining consent. This procedure helps
ensure that only the current, IRB-approved informed consent document is presented to
subjects and serves as a reminder to the investigator of the need for continuing review.

2
Informed Consent Checklist
Include these items in the form: (NOTE: The form should be written at no higher than
an eighth grade reading level. FOLLOW THE SAMPLES [INCLUDING
HEADINGS] found on the IRB website.)
1)

With the Revised Common Rule that went in effect in January 2019 studies
with longer consent forms (more than 1 page) or Federally funded studies a concise
summary is required.
The concise summary is meant to be brief. The purpose of the summary is for the
participant to decide why he/she may want to participate but should also include
information on why he/she may not want to participate in the study (for example a
huge time commitment or other risks). The summary should not include all
foreseeable risks but the risks that would be most likely or most severe to the
participant.
The summary should include the following 5 elements:
1) A statement that the project is research and that it is voluntary.
2) A summary of the research (purpose, overview of procedures etc.)
3) Any foreseeable risks or discomforts
4) Any expected benefits to participants (if applicable)
5) If applicable, alternative procedures to course of treatment

2)

A statement that the potential subject is being asked to participate in a research
project. Include the name of the person who is conducting the research and his/her
title/department. If the principal investigator is a student, the faculty sponsor should
also be identified with his/her affiliation.

3)

An explanation of the purpose of the research.

4)

A description of the procedures to be followed. Include sample questions from any
instruments that may be used (not required for mail/internet surveys where the
questionnaire is enclosed/follows the consent).

5)

An estimate of the amount of time it may take to participate.

6)

A risk statement (reasonably foreseeable risks or discomforts). Examples: in some
studies, answering questions may cause people to become uncomfortable; for
studies involving standard blood draws, the possibility of bruising exists. For studies
that have no foreseeable risks, examples include, “There is no more risk to you in
participating than in everyday living,” or “Except for your time and inconvenience,
there are no risks to you from participating in this study.” Do not state that there are
no risks – all studies have risks even if only time and inconvenience! Do not state
“You could become uncomfortable answering questions and except for your time
and inconvenience, there are no risks to you from participating.” If someone could
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become uncomfortable answering questions, the risk is more than time and
inconvenience – it’s one or the other.
7)

A description of any potential benefits to the subject or to others that may
reasonably be expected from the research. It is possible that a study will have no
direct benefit to the participant! (e.g., “While this study will have no direct benefit
to you, this research will help us learn more about…”). There should be two
statements – benefit of the research to the participant and benefit of the research in
general.

8)

A description of compensation, if applicable. List any compensation for
participation (money, course credit, etc.). Also indicate how compensation will be
handled if a participant withdraws from the study. Do not include if there is no
compensation.
NOTE: If the compensation exceeds $75 in value, the following language should be
added to the Compensation Section (See Human Subjects Payment Guidelines for
additional information.).
Basic information (your name and address, date of payment, value of payment, my
name as researcher) will be given to a University office for tax reasons:
Employee of UMaine (including student employee): Information will
be sent to the Human Resources Department. The value of the
compensation may be added as wages and subject to taxation.
Non Employee: Information will be sent to the Purchasing
Department. If you receive $600+ during a calendar year (January 1
– December 31) from participating in UMaine research projects,
Form 1099 will be generated and mailed to you. If you do not receive
that much money, information will be destroyed at the end of the
calendar year (i.e., December 31st).

9)

For treatment studies only, include a description of appropriate alternative
procedures or courses of treatment that might be advantageous to the subjects.

10)

A description of confidentiality. Will names be associated with the data? Will the
data be coded and linked to a master list of names (key)? Who will have access to
the data? Where will the data be stored (e.g., locked office, password protected
computer)? If you are keeping the key electronically, you need to encrypt it (see
guidelines on encryption. Explain the retention of the data (including any audio,
video, or film recordings): a) if coded, when will the key be destroyed? and b) How
long will the data be kept (e.g., destroyed by date, kept indefinitely, etc.)? Is the
study anonymous? Don’t confuse anonymity and confidentiality. If names are
connected to data (even if you have coded the data), you can’t tell participants that
their identity will remain anonymous! You can only guarantee anonymity if no one,
including you as the researcher, can identify participants. If participants will be
involved in a group interview, you can assure them that you will keep their
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responses confidential and will ask other participants to do the same, but you cannot
absolutely guarantee that other group members will keep their responses
confidential. Use dates (month/year) for destroying keys, data, etc., if applicable. Do
not simply say “upon completion” or “when all data have been collected.”
Participants don’t know when that will be!
11)

A statement that participation is voluntary. If subjects choose to participate, they
may stop at any time or skip any questions they do not wish to answer. If the study
involves compensation such as payment or course credit, make sure it is clear what
happens if they drop out (e.g., do they have to complete the entire study to receive
the compensation, is there partial compensation for completing part of the study, or
do they receive the compensation regardless of the length of participation (e.g., “you
may stop at any time without loss of research credit”).
For an anonymous mail survey, include the statement, “return of the questionnaire
implies consent to participate” (if electronic, use “submission”).

12)

An explanation of who to contact for answers to questions about the research
(include name, phone, e-mail). If a student is the principal investigator, also include
the same information for the faculty sponsor. Also include a statement directing
people to the Office of Research Compliance, University of Maine, 207-581-2657,
umric@maine.edu, if they have questions about their rights as a research participant.

13)

A statement that their signature (if not exempt) indicates they have read and
understand the information and agree to participate. Indicate that they will receive a
copy of the form. The investigator should NOT sign the consent form – doing so
gives the appearance of a contract, which is not accurate.

Other suggestions:
•
•
•
•
•
•
•

Use familiar words, e.g., “cholesterol” instead of “blood lipids.”
Avoid using scientific, medical, or legal terms – if you must use them, define them.
Avoid abbreviations or acronyms.
Use bullets if procedures are lengthy.
For ease of reading, have “white space” on the form.
Know your target population. For example, if you are studying the elderly, use a
larger font size.
Have someone else outside your discipline read the informed consent for
readability/comprehension.
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How to Request a Modification to a Previously
Approved Study
Follow these simple steps to modify an existing stu dy:
1. Using a different color fo nt (or track changes), edit all applica ble sections of the
previously approved application (make sure you ar e using the fin al approved copy).
Make sure new recruitment materials (emails/flyers), new measures, new consent

Forms and Samples
Application Deadlines

forms, etc., ar e included, as applica ble. Note that cha nges in the procedure often
need to be refl ected in the consent (e.g., adding measures may increase the time
needed to comp lete the study). This edited application should be ONE document

Resources
!RB FAQs

(Word only; no PDF).

2. Please note that if you have already collected data but now want to change
methods/measures going forward, you need to r etain all of your original approved
materials in the application and then add the modifi cation describing what yo u want
to do differently in the future.
You should clearly designate the original procedures vs. the new procedures. The
application needs to refl ect the entirety of th e proj ect.
3. Send an email to umric@maine.edu requesting the modification. The email should
refer ence the title and number of the approved application, an d briefly describe the
modification. Attach the updated application and send .

When is a modification really a new study?
If the proposed modifi cation includes changes to t wo or more of the following criteria, the
IRB wou ld consider this to be a new study and the investigator wou ld need to submit a
new study application.
1. Study population

2. Study procedures
3. Study purpose

Change in Personnel
If yo u simply need to update personnel on an approved study, you do not need to edit
the approved application. An email referencing the study t itle and number along with
name of person(s) to be added, years of human subjects r esearch experience, ro le on the
project, and email is sufficient. If the CITI training was not com pleted through UMaine
please also provide the training certificate.
Some personnel changes may also require a change to other sections of the application
such as the consent document, and r ecruitment materials. In such cases, the application
should be modified to include these cha nges and submitted as a modification for review.
Please co ntact the IRB office with any questions.

Human Subjects

Internal Institutional Dat a Collections
IRB Overview
Internal institution al data collections are typically n ot co nsidered research* and,

Guidance & Policy

therefore, review by the Institutional Review Board for the Protection of Human Subjects
(IRB) is not required. Internal data collections are most often used to change/improve a

Regulations

campus service. Examples inclu de:

Training
1. Surveys of dining preferences

Forms and Samples

2. Eva luati ons of student satisfaction for accred itation reports
3. Exit surveys for graduates or employees

Application Deadlines

4. Surveys to determine residence hall programming needs

Resources
If an internal institutional data collection follows the examples and purpose stated above

!RB FAQs

(i.e., to change/improve a campus service), IRB review is not required. If you have any
q uestions on wh ether a proposed internal institutional data collection requires IRB
review, please contact the IRS Office.

*Research is de fined a s: "a s yste matic investigation, induding <e se.arch deve lopme nt, testing and evaluation, designe d

,o develop o r contrib ute to generalizable knowledge." [45 CFR 46,1 02(d)) Generalizable knowledge is information
which h as the potential to b e expanded from the isolat ed circum stan ces in which it is acquired to any broader context.
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Human Subjects

Reactivating a Closed Study
IRB Overview
Re -opening a closed stu dy is handled on a case by case basis by the IRS. You can request

Guidance & Policy
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reactivating a closed study up to 12 months after the study was closed. After this time, a
new application submission will be required.
To r e-open the study the Pl must submit the following:
1. The reason why the study was closed an d the r eason why it needs to be re-opened.
2. Confirmation that no participants were enrolled an d no data collection occurred

Application Deadlines

wh ile the study was cl osed and that this is the continuation of the same stu dy.

Resources

3. If applicab le, a modification with any requested changed to the application,

!RB FAQs

4. An updated continuing review (if applicable) w ill need to be submitted.

personnel, etc. since t he application was last approved.
5. If participan ts need to be notified of the re-opening, the Pl must explain how this w ill
be accomplished.

ATTENTION RESEARCHERS:
This is a template for a handout to be used for studies on sensitive topics where referrals are required. Edit as
necessary and delete this row containing these instructions. Be sure to provide names of organizations (with
contact information and hours of operation) that are relevant to your specific study. All contact information must
be accurate and up-to-date. National directories may be appropriate for online studies where the locations of
subjects are unknown.

Counseling Services
ON-CAMPUS RESOURCES
Available for UMaine Faculty, Staff, and Students
Counseling Center
Cutler Health Building (Gannet Hall side)
(FREE to UMaine students)
Psychological Services Center
330 Corbett Hall
(Sliding fee scale; costs are your responsibility)

207-581-1392

Weekdays 8:00 am-4:30 pm
After business hours, call UMaine
Police, 581-4040 or 911

207-581-2034

Weekdays 8:00 am – 4:30 pm

http://www.umaine.edu/counseling/

https://umaine.edu/psychology/psychologicalservices-center/

COMMUNITY RESOURCES
Available to Anyone
Community Health & Counseling Services
42 Cedar Street
Bangor, ME 04401
(Any costs are your responsibility)
Maine Crisis Hotline
(Any costs are your responsibility)
Psychological Services Center
330 Corbett Hall
(Sliding fee scale; costs are your responsibility)

207-947-0366

http://www.chcs-me.org/

1-888-568-1112

https://heretohelpmaine.com/

207-581-2034

https://umaine.edu/psychology/psychologicalservices-center/

Contact Your Primary Care Provider
(Any costs are your responsibility)

NATIONAL RESOURCES
Behavioral Health Services Locator https://findtreatment.samhsa.gov/
National Suicide Prevention Lifeline, Toll-Free, 24-hour Hotline, 1-800-273-TALK (1-800-273-8255)

Weekdays 8:00 am-5:00 pm

7 days/week 24 hours

Weekdays 8:00 am – 4:30 pm

Human Subjects
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Considerations When Assessing Sex and Gender in
Research
The IRB at the University of Maine encourages researchers to be sensitive to and inclusive
of differences when collecting data about identities of participants.

Training
Forms and Samples
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Definitions
Gender/Gender Identity is a pers on's internal held sense of their gender, regard less of
biology.

Resources
Sex refers to biological differences between males and fema les, such as the genitalia and

!RB FAQs

genetic d iffer ences. Sex is assigned at birth.
Sexual Orientation is a t erm used to describe one's pattern of emotional, roma ntic
and/or sexual attraction.

Sample Questions
Below are sample q uestions and response options for gender identity, sex, and sexual
orientation.
1. What is your current gender identity? (Check all that apply.)
• Male
• Female
• Transgen der fema le I t rans woman (or Male-to-Female (MTF) tran sgender,
t ranssexual, or on the tra ns fema le spectrum)
• Transgender male I trans man (or Female-to-Male (FTM) t ransgender, transsexual, or

o n the trans male spectrum)
• Non-binary, genderqueer, or genderfl uid
• Gender identity not listed:
• Pr efer not to r eply
2. Wh at is your sex assigned at birth?
• Male
• Female
• lntersex
• Not Listed:
• Pr efer not to r eply
3. What is your sexual orientation?
• Heterosexual/Straight
• Gay/lesbian
• Bisexual
• Pansexual
• Not listed:
• Pr efer not to r eply
4. [If investigators w ill refer to participants directly it is r espectful to ask which pronouns
they should use]:
What pronouns would you like study staff to use when referring to you? (The Pis
may want to consider introducing themselves by name and pronouns to
demonstrate w hat this looks like an d to indicate that this is an inclusive space).
o He/him/his
o She/h er/hers
o They/them/theirs
o Other (please specify):

Tips for Researchers
• Use the term sex wh en reporting biological fa ctors and gender when reporting
gender identity, psychosocial or cu ltural factors.
• Consider if it is relevant to the study to include questions r egarding sexual health
history and/or sexual orientation.
• Sex, gender identity, and sexual orientation are both sensitive and personal
characteristics. Therefore, it is important to protect this informat ion, especially when
recorded as identifiable. Investigators must ensure that research subjects provide
this informati on in a locat ion where they are comfortable and that ensures their
privacy.
• All study docum ents (including surveys) should use gender-neutral language,
avoiding gendered terms (e.g., mailman, chairman) and gender ed pron ouns (he,
she, he/s he). Gendered terms should be rep laced w ith non-gendered versions (e.g.,
mail carrier instead of mailman o r chairperson instead of chairman). Sentences
using gender ed pronouns should ei ther use gender-neutral pronouns (e.g., singular
they as in "Each subj ect will receive their gift card upon com pleting the study.") or be
reworded entirely to avoid such pronoun use (e.g., "Subjects will receive their gift
card upon com pleting the study.").
Avo id presuming roles w henever possible. For example say "spouse/ partner"
instead of "husband/wife".

Incorporate gender neutral diagrams in research materials.
• Do not assume pronouns w hen interacting w ith a subject until they identify a
preference.
• Train your research team members to increase t heir com fort level in asking an d
answering sensitive questions about gender and sexual orientation from subjects.
The FenwaY. Institute is a good source for tra ining materials.

References and Resources
ReP-orting Sex, Gender, or Both in Clinical Research

Guidelines and tips for collecting_patient data on sexual orientation and gender identity
Sex and Gender E!;]uitY. in Research: rationale for the SAGER guidelines and recommended
use
Canadian Institutes of Health Research Online Training Module
Reviewer Guidance to Evaluate Sex as a Biologica l Va riable (NIH)
Inclusion of sex and gender in biomedical research: SurveY. of clinica l research 12ro12osed
at the Universify. of PennsY.lvan ia
UHSRC Guidance: Use of Gender Inclusive Languag~
Sex and Gender Research Considerations (Tufts)
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Human Subjects
What is GDPR?
IRB Overview
The General Data Protection Regulatio n (GDPR) is a European law that went into effect

Guidance & Policy
Regulations
Training

May 2, 2018 an d establishes protections for privacy and security of "personal data" about
individuals in t he European Economic Area (EEA).
Please note that GDPR considers "coded date" to b e "personal data" even where one lacks
access to the key-code/cod ing system required to link data to an individual data subj ect.

Forms and Samples
Application Deadlines

This is in contrast to US r egulation protecting human subj ects.

What countries are part of the EEA?

Resources
Austria, Belgium, Bulgar ia, Croatia, Repub lic of Cyp rus, Czech Republic, Denmar k, Estonia,

!RB FAQs

Finland, Fra nce, Germany, Greece, Hungary, Iceland, Ir eland, Italy, Latvia, Liechtenstein,
Lithuania, Luxembourg, Malta, Nether lands, Norway, Poland, Portugal, Romania, Slovakia,
Slovenia, Spain, Sweden, and the UK.
Please note that the participant does not need to b e an EEA resident for the GDPR to
apply.

Under GDPR what is considered "Person al Data"?
Information t hat relates to an identifi ed pers on. Examples are: name, email, IP address or
cookie number, personal character istics (this also incl udes photographs).
Additional protections are given to sensitive personal information such as race, politica l
opinions, religious beliefs, genetic data etc.

Tips on how to com ply with GDPR?

If the study can be completed using de-identified data that wou ld be the best option. If
you need to collect personal data co llect the minimum amount of demographic/personal
data n ec essa ry.
Be awar e that online survey sites often collect IP addresses by defau lt so make sure yo u
set up your survey to collect only the information you need for the study.
If you ar e collecting identifiable data you need to have a plan on how you will remove the
data if the participant r equests this.

How to ensure consent process complies with GDPR?
The consent process needs to be active so for example, in an electronic survey the
part icipant should click to consent to proceed with the survey. It must be an affirmative
action.
Yo u must maintain consent records for the participants. For example, if the participant is
giving verbal consent you must maintain a log with t he subj ect name or ID and the date
and time consent was provided.
Consent fo rms must contain the following information:
• Who is collecting the information? (must include contact information of per son(s)
collecting the information)
• What information is being collected?
• How is the in formation collected?
• How will the information be used?
• How w ill information be stored and fo r how long?
• Who w ill data be shared with?
• How does a part icipant withd raw from the study? (The participant needs to be
inform ed of their rights to request access, er asure, and/or obj ect to the processing
of the data.)
Additional information about GDPR

Human Subjects
Zoom Guidance fo r IRB Stu dies
IRB Overview
When using Zoom technology, at a minimum, please follow the guidelines outlined below:

Guidance & Policy
1. Participants should be reminded to protect their privacy by com pleting activities

Regulations
Training
Forms and Samples

in a private and quiet space, to ensure conversati ons are not overheard and ensure
that t her e are minimal interrupt ions.
2. Researcher should establish ground rules with participants; t his could incl ude not
taking screen shots, not recording the session etc.

Application Deadlines
3. Passwords should be used fo r Zoom meet ings with research parti cipants.

Resources
4. Participants should be told how and where Zoom r ecord ings are saved.

!RB FAQs
To disable Cloud Recordings (this is the preferred setting for recordings)
follow these steps:
■

In the "Meeting Settings" select th e "Recording'' tab.

■ Turn ON the "Record on the local computer" option.
■ Turn OFF the "Cloud Recording" op tion .
■ This enables you to save both aud io and video fil es of Zoom recordings to

your computer.
If using Cloud Recordings: In some cases, it may be necessary for you to use
Cloud Recordings in ord er to utilize Zoom's "Audio Transcript'' feature. If you
would like to create Cloud Recordi ngs, p articipants must provide their co nsent.
You must include t he fo llowing information in t he "Confidentiality" section of
the co nsent form:
■ Tell participants that r ecordings w ill be stored on the Zoom Cloud and tell

them w I1en those r ecordings w ill be d eleted (recordings should be
d eleted as soon as possible from t he Zoom Cloud).
■ Tell part icipants that the record ings are subj ect to Zoom's P-rivacy_P-olicy.

You have flexibility on how to pr esent Zoom infor mation to participants.
Reminders can be part of consent fo rm or recr uitm ent script, or at the
beginning of the Zoom session.
NOTE: The free and regular paid versions of Zoom are not HIPAA com pliant and
should not be used for any study involving the collection or use of protected health
information (PHI).

Human Subjects

Federal and State Regulations & Guidance Materials
IRB Overview
Guidance & Policy
Regulations

OHRP - Office for Human Research Protections
• 45 CFR 46 - Federal Regulations for the Protection of Human Subject - applies to
ALL human subjects studies

Training
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NIH - National Institutes of Health
• Education Re~u irement - FAQs r egarding the NIH Education Requirement
• Special Topics:

Resources

o Certificates of Confidentiali ty,

!RB FAQs

o Data Sharing
o Inclusion Policies for Research Involving Human Subj ects
o Single IRB

NSF - National Science Foundation
• Human Subj ects - NSF Policy for human subjects resear ch (HSR)
• Behavioral and Social Science Research - NSIF interpretation of Common Rule and

Behavioral and Social Science Research

FDA - Food and Drug Administration
Studies using investigational drugs, devices or biologics
• 21 CFR 50 - FDA Regu lations for Protection o f Human Subjects
• 21 CFR 56 - FDA Regu lations for Institutional Review Boards
• Guidance for interP-reting 21 CFR 50 and 56

• ComP-arison of FDA and HHS Human Subject Regu lations

VHA - Veterans Health Administration
• ORO - Office of Research Oversight

HIPPA Regulations
• 45 CFR 160, 162 and 164

DoD - Department of Defense
• DoD Directives
• DoD Instruction

General
• The Belmont ReP-Ort
• The Nuremberg Code
• Declaration of Helsinki ("The World Medical Association has developed the
Declaration of Helsinki as a statement of ethi ca l principles to provide guidance to
physicians and other part icipants in m edica l research involving human subjects.")
• The Common Rule - Federal Policy for the Protection of Human Subjects

Human Subjects
IRB Overview
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Requ ired Training for the Protection of Human
Subjects
ALL personnel named in an existing or new "Application for Approval of Research with
Human Subj ects" must com plete the Collaborative Institutional Training Initiative (CITI)
web-based training on the protecti on of human subjects (this includes facu lty sponsors

Training
Forms and Samples
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on student stu dies).
Instructions for CITI Training_{PDF)

The CITI training is valid for four years from the date of completion. After four years, the

Resources

"refresher" m odules will need to be com pleted (you will receive a reminder from CITI).

!RB FAQs

It is estimated that the training will take 1 hour. Passing score for quizzes is 80%. The
components of the CITI training include:
• Basic Courses in the Protecti on of Human Research Subj ects. While there are four
choices w hen enrolling, t he one that should b e taken for the majority of UMaine
faculty, sta ff, an d students is Social and Behavioral Research Investigators. The
Biomedical Research Investigators co urse can be selected for resear chers that ar e
cond ucting mostly biomedi cal research.
• Electives: These electives do not appear until you have com pleted the main course.
Select the ar ea(s) pertaining to your research. You might need to ta ke mor e than
one, bu t you ar e required to ta ke at least one. If none of the electives seems
relevant to your research, we suggest Con flicts of Interest in Research Involving
Hum an Subj ects or Internet Research.
o Confl icts of Interest in Research Involving Human Subj ects
o Internat ional Research
o Internet Research

o Research with Children
o Research w ith Prisoner s
o Research in Public Elementary and Secondary Schools (we recognize the
heading states "Public," but please take this module if yo ur research is
conducted in private elementary/secon dary schools)
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Instructions to Access CITI Training
Office of Research Compliance (ORC), University of Maine

The Office of Research Compliance (ORC) delivers a variety of research training through the
University of Maine System (UMS) subscription service to the Collaborative Institutional
Training Initiative (CITI). These instructions guide you through the institution-specific CITI
registration and enrollment processes. Further information about Research Compliance at the
University of Maine and training requirements can be found on the ORC website.
IMPORTANT NOTE: You are only required to complete the training(s) for your specific area(s)
of research compliance.
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I.

Establish a CITI Account
a. Please note: if you have previously set up a CITI account, please do NOT
create another one. See Section II (Log into CITI as an Existing User) of this
document for guidance.
b. Go to CITI Program (https://about.citiprogram.org/) and click on the white
“Register” button located in the upper right hand corner of the homepage.

c. Search for ‘University of Maine System’ in the section titled ‘Select your
Organizational Affiliation’ and click on it.
i. Click the check boxes to agree to the CITI Terms of Service and Privacy
Policy, and to agree that you are an affiliate of the University of
Maine System.
ii. Click the “Continue to SSO Login/Instructions”
iii. Note: No action is needed in the bottom section titled “Independent
Learner Registration.”

2

d. Under “Associate your SSO account with a CITI Program account” click “I
don’t have a CITI Program account and I need to create one.”
i. Click the button that appears below labeled “Create A New CITI
Program Account.”

ii. This will automatically create an account for you using your UMaine
SSO (Single Sign-On), the same login information used to log into the
UMaine Portal, etc. You should also receive a confirmation email via
your maine.edu email address with this information.

II.

Log into CITI as an Existing User
a. To log into CITI once you have established your CITI account, go to CITI
Program (https://about.citiprogram.org/) and click the blue “Log In” button
located in the upper right hand corner of the homepage.

b. On the login page, click the center option labeled “Log In Through My
Organization.”
c. On the list of organizations that appears, click on “University of Maine
System” and you will be logged in using your UMaine SSO.
d. NOTE: if you already had an account set up with CITI from another
institution, you can affiliate that existing account with UMaine. See
instructions from CITI on how to add/change your affiliated institution.
3

III.

Enroll in CITI Courses
a. New Users
i. After you enroll, you will be brought to your “My Courses” page.
Under “Institutional Courses,” click the button next to University of
Maine System labeled “View Courses.”

ii. You will be brought to the “Select Curriculum” page. Select any
desired course(s) from the list. See section IV (Required Trainings) of
this document for details on which specific trainings are required for
each area of research.
iii. Once you have made your selection(s), hit the “Submit” button at the
bottom of the page (Note: you are able to sign up for additional
courses later, after you have made this initial selection – see section
III.b [Returning Users] of this documentfor instructions).
b. Returning Users
i. After logging into CITI as a returning user, you will be brought to the
“My Courses” page. Click on the “View Courses” button next to the
University of Maine System (as shown above under New Users).
ii. On this page, you will see a list of all courses you are currently
enrolled in and have previously completed.
iii. To enroll in another course, scroll to the very bottom of the page to
the section labeled “Learner Tools for University of Maine System.”
Click the link for “Add a Course.”
iv. You will be brought to the “Select Curriculum” page. Select any
desired course(s) from the list. See section IV (Required Trainings) of
this document for details on which specific trainings are required for
each area of research compliance.
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IV. Required Trainings
PLEASE NOTE: You are only required to take the trainings for your specific area(s) of
research compliance.
If you are unsure of which trainings may be required for your research, please explore
the resources available on the ORC website and reach out to the ORC for additional
guidance as needed.
Once you know which trainings are required for your research, find the relevant
compliance area below and follow the instructions to sign up. See section III (Enroll in CITI
Courses) of this document for instructions on how to enroll as a new or existing CITI users.

a. Animal Care
i. Visit Animal Care on the ORC website for guidance on when and for
whom this training is required.
ii. To enroll, on Question 6, select the required course “Working with
the IACUC” (as shown below). In addition to the required “Working
with the IACUC” course, we strongly recommend you take modules
from these sections that apply to your research.

List continues – see the CITI enrollment page for the full list of available modules. In
addition to the required “Working with the IACUC” course, we strongly recommend
you take modules from these sections that apply to your research.
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b. Biosafety
i. Visit Biosafety on the ORC website for guidance on when and for
whom this training is required.
ii. To enroll, on Question 7, select the following 4 courses:
1. Introduction to Biosafety
2. Basic Biosafety Training (Note: after enrollment, on My
Courses page, the title will appear as “Training for
Investigators, Staff and Students Handling Biohazards.”)
3. Select Agents, Biosecurity and Bioterrorism
4. NIH Recombinant DNA (rDNA Guidelines)
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c. Conflict of Interest
i. Visit Conflict of Interest on the ORC website for guidance on when
and for whom this training is required.
ii. To enroll, on Question 5, select “Conflicts of Interest (All OTHER
University of Maine System Campuses).”

d. Export Control
i. Visit Export Control on the ORC website for guidance on when and for
whom this training is required.
ii. To enroll, on Question 8, select “CITI Export Controls.” (Note: after
enrollment, on My Courses page, the title will appear as “CITI Export
Controls Course.”)
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e. Human Subjects
i. Visit Human Subjects on the ORC website for guidance on when and
for whom this training is required.
ii. On Question 1, select one learner group based on your role and the
research you will be conducting. You will be able to go back and add
another learner group later on, if needed.
1. The most common selection is “Social & Behavioral Research
Investigators,” shown below. (Note: after enrollment, on My
Courses page, the title will appear as “Social & Behavioral
Research - Basic/Refresher.”)
2. The Biomedical Research Investigators course can be selected
for researchers that are conducting mostly biomedical research.

f. Responsible Conduct of Research
i. Visit Responsible Conduct of Research on the ORC website for
guidance on when and for whom this training is required.
ii. On Question 4, select “General Responsible Conduct of Research
Course.” (Note: after enrollment, on My Courses page, the title will
appear as “General RCR.”)
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As a reminder, please note that you are only required to take the trainings for
your specific area(s) of research compliance. If you are unsure of which trainings
may be required for your research, please explore the resources available on the
ORC website and reach out to the ORC for additional guidance as needed.

V. Access CITI User Records and Reports
a. Users can access training records and Completion Reports through the “My
Records” link in the menu bar at the top of the CITI page.
b. CITI will automatically alert ORC when you complete training, however there
is a slight delay. ORC is also able to view in CITI when your training is
complete. Please do not need to send copies of completion reports to ORC.
i. If you require immediate assistance (i.e. you've just completed
Financial Conflicts of Interest training and need access to PARS),
please contact sponsored@maine.edu.
ii. For all other CITI training inquiries, please contact umric@maine.edu.
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APPLICATION COVER PAGE
• KEEP THIS PAGE AS ONE PAGE – DO NOT CHANGE MARGINS/FONTS!!!!!!!!!
• PLEASE SUBMIT THIS PAGE AS WORD DOCUMENT
APPLICATION FOR APPROVAL OF RESEARCH WITH HUMAN SUBJECTS
Protection of Human Subjects Review Board, 311 Alumni Hall
(Type inside gray areas)
PRINCIPAL INVESTIGATOR:
CO-INVESTIGATOR:
CO-INVESTIGATOR:
FACULTY SPONSOR:
(Required if PI is a student):
TITLE OF PROJECT:
START DATE:

EMAIL:
EMAIL:
EMAIL:
EMAIL:
PI DEPARTMENT:

STATUS OF PI: FACULTY/STAFF/GRADUATE/UNDERGRADUATE

(F,S,G,U)

If PI is a student, is this research to be performed:
for an honors thesis/senior thesis/capstone?
for a doctoral dissertation?
other (specify)

for a master's thesis?
for a course project?
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in Section I.E. of the Policies and Procedures for the Protection of Human Subjects.
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Review (F/E):
Expedited Category:
ACTION TAKEN:
Judged Exempt; category
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Accepted (date)
Approved as submitted. Date of next review: by
Degree of Risk:
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Degree of Risk:
Modifications accepted (date):
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Judged not research with human subjects
FINAL APPROVAL TO BEGIN
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10/2018
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IRB APPLICATION FORM INSTRUCTIONS
DO NOT SUBMIT WITH APPLICATION
Things to remember when completing the application cover page:
• The principal investigator must have a UMaine affiliation.
• Faculty sponsor required if the principal investigator is a student.
• The title should describe the specific subject matter to be researched. If the study is
funded, the title must match the grant/proposal.
• The start date refers to when the research with human subjects proposes to begin,
and should not be earlier than ten days from the date the application is submitted.
• Submit as WORD DOCUMENT (not a PDF).
Please note:
•
•
•
•
•

•

Please read and follow instructions; incomplete applications will be returned.
FACULTY SPONSORS: you are responsible for the quality of the application; do
not approve an application that is incomplete or does not follow the instructions – it
will be returned to you.
For undergraduate students, the application MUST BE SUBMITTED (EMAILED)
BY THE FACULTY SPONSOR.
Type responses to points below; please include the nine major headings detailed below
(e.g., Funding, Summary, Personnel, Participant Recruitment), but do not include the
application instructions.
Page number entire document. PLEASE SUBMIT AS ONE DOCUMENT. The Cover
page should be submitted separately (and kept as Word document), but the narrative of
the application (items 1-9 below), with appendices (measures, recruitment materials,
consent forms, etc.) should be one document.
Please submit the document as ONLY a Word document (not a PDF).

Application Narrative:
1.

Funding: if the proposed study has been submitted for funding or is funded, please
list funding agency and grant/proposal number, if known. Note that the title of the
IRB application should match the title of the grant. If the study is not funded, state
N/A

2.

Summary:
Describe the rationale of the study in concise, non-technical language.
• Although the IRB does not wish to receive grant/dissertation proposals, this
section should include a description of the scientific significance and goals of the
study, including background information and citations, to justify conducting the
study. The background information should also explain the rationale for the
choice of the particular participant population, as well as the use of specific
measures and procedures.
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•

•
•

Include a methods section (with “Methods” heading). This section need not be
long, but the IRB wants to understand early on how the study will be conducted.
Some can be as brief as: “This study will involve face-to-face interviews at a
location of the participant’s choosing. The interviews may take 45-60 minutes and
will be recorded.” This section would be longer if there are many components of
your study.
Include a reference page for the citations (we expect to see citations!).
Include questionnaires, interview questions, measures, etc., as appendices.

2.

Personnel:
• Identify the person(s) named on the cover page (including the faculty sponsor, if
applicable), as well as others who will have contact with the participants and/or
with identifiable data. (NOTE: Make sure principal investigator is named; do not
state: “I will be the principal investigator.” Be sure to define the roles that the
named personnel will have in the research project.
• Specify the affiliation/qualifications of everyone listed, e.g., “Jane Doe, Graduate
student in the Department of Psychology, College of Liberal Arts and Sciences.”
Briefly explain each person’s experience with research with human participants.
Include the years of human subjects research experience for all personnel listed.
• Everyone named in this section is required to have completed the human subjects
training.

3.

Participant recruitment:
• Describe the characteristics of the participant population. Describe the expected
number of participants or the expected response rate (e.g., plan to send out 500
surveys and expect 20% response rate). Include the age range of the participants
and whether particular demographics and characteristics (e.g., state of health) are
sought. If you are recruiting only one gender, explain why. (NOTE: if you are
specifically recruiting members/citizens of the Penobscot Nation, please be sure
to state they are your targeted population.)
• Describe how the proposed number of participants was determined.
• Describe participant identification and recruitment procedures, e.g., email
(explain how are email addresses obtained), post flyers, etc. If you plan to recruit
participants from another institution, please be aware that you may need to get
permission from that institution to access participants and, if applicable, get
approval from that institution's review board. Please note that if you are seeking
participants with a specific physical or mental health condition, you CANNOT
ask a professional services provider to give you a list of names of individuals who
fit your criteria. However, these service providers may share your recruitment
materials with those who appear to be eligible for your study, and interested
individuals can contact you directly. Include (as appendices) recruitment letters,
phone/email scripts, flyers, advertisements, postings, etc., that may be used to
recruit participants (see samples on the IRB website). Reference the appendix
number/letter.
Please note: The IRB requires special measures of protection for participants of
diminished autonomy. (See Sections II, III, and/or IV from Policy.) Vulnerable
populations must be treated with special sensitivity to their restricted ability to protect
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themselves. The risks imposed by a proposed study involving such populations must be
recognized and the benefits to be derived from participation must justify the risks. In
certain instances, advocates must be appointed to protect the participants. Such
populations include fetuses (and by extension pregnant women), patients, prisoners or
parolees, minors (less than 18 years old), and mentally or physically challenged people.
In addition, the IRB may require special measures to preserve the rights of participants
whose circumstances may make them vulnerable to undue influence to participate in
research. These may include, for example, students and employees of the University.
State which, if any, of the above groups may be represented in your participant
population, and justify their inclusion.
4.

Informed consent (See Sections I.K. and I.L. of Policy):
• Describe the type of consent (oral or written) to be used and the means of
obtaining it. Describe how and when potential participants will get the consent
form.
• If the participants are minors or mentally incompetent, describe the means of
obtaining both the participants' assent (if feasible) and the consent of parents or
legal guardians.
• Include a copy (in an appendix at the end of the application) of the consent
form(s) and assent scripts (if applicable). Consent forms should be written no
higher than an 8th grade reading level.
• Review the informed consent checklist and FOLLOW THE SAMPLE(s)
FOUND on the IRB website Please note: The documentation (signature) of
informed consent is not necessary for a project in one of the exemption categories.
THE SAMPLE FORMAT, WITH HEADINGS, MUST BE FOLLOWED OR
THE APPLICATION WILL BE RETURNED.

5.

Confidentiality:
• Describe the precautions that will be taken to ensure privacy of the participants
and the confidentiality of the data, both in your possession and in reports and
publications (e.g., are responses anonymous, are responses coded with
identification numbers and a key used to link names to identification numbers).
• If data collection will occur on-line, state the program that will be used (e.g.,
Qualtrics, Skype, etc.). If applicable, state whether IP addresses will be collected
(preferable that they are not collected!). State whether data will be downloaded
off program to researcher’s computer, as well as the expected date data will be
deleted off the program site.
• State the location where data will be stored. Describe the disposition of the
research data, including any audio, video, or film recordings, when the research is
completed (define as expected date to be destroyed or kept indefinitely). If not
keeping indefinitely, don’t say “kept until study completed,” or “when analysis
completed,” etc. State an approximate date (month/year) of those occurrences,
e.g., January 2024. If you are not keeping data indefinitely, be sure to be
generous with a destruction date, so you don’t end up in a situation where
you are not ready to destroy the data, but must because that is what you told
the participant – NOTE: if you say you will keep the data indefinitely, you
can destroy it at any time—but if you give an actual date, you must adhere to
it!
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•
•

•
•
•
•

If recording, state whether a transcription service will be used or if named
investigator(s) will transcribe.
If applicable, state whether the key is paper or electronic and where and how long
the key will be kept (key should be kept separate from data). Keys are typically
kept for a lesser amount of time than data are kept. Use a date for destroying the
key, but give yourself plenty of leeway with the timing in case your project gets
delayed. If you wish to keep the key indefinitely, please explain why, as it
impacts participant confidentiality. If the key will be stored electronically, it must
be encrypted. Please see information on encrypting electronic, identifiable data
(the key linking names to data or entire dataset).
Assurance must be provided that all identifiable data will be secured under
conditions that limit their access to the investigator(s) only.
If focus groups are used to collect data, the researcher should acknowledge that
he/she cannot guarantee confidentiality of participants’ responses, but will
encourage participants to not discuss responses outside of the focus group.
If the data are published, care must be taken to remove identifying references in
order to preserve privacy.
The IRB recognizes that some studies, such as oral histories, do not require
confidentiality of data. The regulations and the IRB are flexible – explain what
will happen with the data. If applicable, explain why data will not be confidential.

6.

Risks to participants:
• Describe in detail any possible physical, psychological, social, legal, economic, or
other risks (including a risk of identification) to the participants, either immediate
or long range. Do not state that there are no risks. All studies have risks (e.g.,
time and inconvenience).
• If the participants will be exposed to greater than minimal risk, justify the use of
the procedures and state reasons for not using a procedure that would entail a
lesser risk.
• Describe procedures used to minimize risk (e.g., assuring participants that they
may skip questions they prefer not to answer). If applicable, include referrals to
relevant resources from which participants could seek support. Use the Referral
Handout Template and edit as necessary.
• Describe what procedures will be followed if research procedures reveal that
participants are at elevated risk (e.g., high blood pressure, clinical levels of
depressive symptoms). See Guidance for Researchers – Depression and
Suicidality in Human Research.

7.

Benefits:
• The description is two parts. (1) Describe the benefits of the research to the
participants, if any (if no direct benefit to the participants, so state). NOTE:
Money, course credit, gifts, etc., are not benefits; they are compensation. (2)
Describe the overall potential benefit of the research.

8.

Compensation:
•

If applicable, list any compensation for participation (money, course extra credit,
raffle, etc.). Also indicate how compensation will be handled if a participant
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•

•

withdraws from the study (e.g., no compensation, prorated compensation, or full
compensation; must reach end of survey to enter raffle; must complete survey,
except for the occasional skipped question, to enter the raffle, etc.). Regarding
extra credit: if extra credit is offered, the course instructor must offer other
methods of earning extra credit such that participating in the research is not the
only way a student can earn extra credit. If a study involves several classes with
different instructors, all must agree to grant extra credit and all must offer other
methods of earning extra credit. Compensation shouldn’t just be for some of the
participants.
For raffle/compensation for on-line studies (where the link to the
raffle/compensation takes the participant to a new page to enter their contact
information), include the text of that page as part of your application. It need not
be long – thanking them for taking the survey, reminding them that their contact
information is not linked to their survey responses, along with place for
name/email/phone, etc.
If the value of a one-time payment exceeds $75.00, subject data must be reported
to other offices within the University of Maine and University of Maine System,
as follows:
o If the human subject is an employee of the University of Maine, the
researcher must report any such payments to the Department of Human
Resources. The Department of Human Resources will determine whether
the value of the reported incentive needs to be added to the employee’s
gross wages, and whether the payment will be subject to taxation and
withholding.
•

If the human subject is not an employee of the University of Maine, the
researcher shall report any such payments to the Department of Purchasing.
The researcher will work with the Department of Purchasing to comply with
IRS regulations that require the University of Maine System to issue a Form
1099 when cumulative payments to a non-employee reach $600 in a calendar
year.

SEE Consent Guidelines for the wording to be used in the consent form.
SEE Human Subjects Payment Guidelines for additional information.

6
Submission Instructions:
•

Email complete application and cover page to umric@maine.edu).

•

REMEMBER – If an undergraduate is the principal investigator, the faculty
sponsor must submit the application.

•

The submission email should have two attachments:
1) The completed cover page as Word document.
2) The narrative of the application (items 1-9 above) along with the appendices -consent form(s), recruitment materials, measures, etc. as ONE document –
PAGINATED.

•

Please note that the IRB expedites many applications (reviews outside of a full board
meeting). The IRB will expedite applications when possible, typically within ten business
days. The IRB will make the final determination of whether your study is eligible for
expedited review.

•

If your study involves sensitive topics, protected populations, and/or more than minimal
risk, the application may require full board review. In those cases, the application is due
by the first Friday of the month for inclusion on the agenda for that month.

Please contact the IRB if you have questions – 207-581-2657 or e-mail umric@maine.edu.

Request for Student Data for Use in Research Project
All requests must be in accordance with FERPA regulations and have Institution Review Board for Protection
of Human Subjects (IRB) approval. If this is a project that a student is conducting, there must be a faculty
advisor that approves the data request.
Storage of this data, either electronic or paper, must be in a secure location and not shared with a third
party.

Requestor’s Information

Name:
Department:

____________

________

Phone: ___________________________

Faculty Advisor (if applicable):
Signature: _____________________________________________

Date: _______________________

Project Information
Purpose of Project:
Data Requested:

_________________

__

How will the data be stored (electronic & paper): ______________________________

_____

At the end of the Project, what will happen to the data:

Approval

Documentation of IRB Approval Attached? ___________
Faculty Approval:
Office of Student Records Approval:
The student and the faculty member will be notified of the approval status of their request.

December 2010/OSR

SAMPLE ASSENT SCRIPT
For studies involving children, an assent script is required. Children with permission to
participate in a research study also have the right to be informed about the study and choose
whether they wish to participate. Create a script that describes the study, what they’ll be asked
to do, confidentiality issues, etc. Use age-appropriate language! Children do not sign any
documents.
Below is a very basic sample script, one that could be used with most young children. For middle
school children, you may include more information and increase the reading level slightly. We
suggest you test your assent script on children you may know to see if they understand what you
are asking. For high school students under 18, it is acceptable to use the parent/guardian consent
form you created and modify it to reflect that it is an assent script directed at them and not their
parent.
Hi, my name is ____________________, and I’m from the University of Maine. I am here today
because I am doing a project to learn about ______________________.
I would like to ask you to _______________ (explain in very simple language the activities the
child will be asked to do). If you say “yes,” you can still stop at any time by just telling me you
want to stop. No one will be upset if you don’t want to do this, or if you want to stop after you
have started. If I ask you a question and you don’t want to answer it, that’s ok. Your parents have
said it is ok for you to be in the project if you want to.
Your answers will be private and only used for my project.
Would you like to be in my project?
NOTE: Depending on the type of study, additional information may be required, e.g., “some
questions could make you sad” (risk statement).

SAMPLE CONCISE SUMMARY
With the Revised Common Rule that went in effect in January 2019 studies with longer consent forms
or Federally funded studies a concise summary is required.
The concise summary is meant to be brief. The purpose of the summary is for the participant to decide
why he/she may want to participate but should also include information on why he/she may not want to
participate in the study (for example a huge time commitment or other risks). The summary should not
include all foreseeable risks but the risks that would be most likely or most severe to the participant.
The summary should include the following 5 elements:
1) A statement that the project is research and that it is voluntary.
2) A summary of the research (purpose, overview of procedures etc.)
3) Any foreseeable risks or discomforts
4) Any expected benefits to participants (if applicable)
5) If applicable, alternative procedures to course of treatment
CONCISE SUMMARY EXAMPLE – Biomedical (non-drug/device study)
You are being asked to join a research study. The research is to help…….
Before you consider the research you should be aware of the following information:






Research is voluntary. You do not have to be in this study.
The study will require 2 visits to the lab for 2 hours (total time of 4 hours).
We will ask you questions about your health.
The study involves a blood draw to collect biomarker information and exercise testing.
If you think you want to be in the study, you should read the rest of this document. The
document explains what will happen to people in the study
CONCISE SUMMARY EXAMPLE – Social and behavioral

You are being asked to join a research study. The research is to help…….
Before you consider the research you should be aware of the following information:







Research is voluntary. You do not have to be in this study.
You will complete pre-screening surveys about your mental and physical health.
You will have your blood pressure and heart rate measured.
If after the screening you qualify for the study, you will return to the lab to complete some
challenging mental stress tests. This part will be videotaped.
The pre-screening will take 1 hour in the lab and the study will take 2 hours in the lab.
If you think you want to be in the study, you should read the rest of this document. The
document explains what will happen to people in the study

SAMPLE CONSENT FORM FOR ANONYMOUS ELECTRONIC SURVEY
You are invited to participate in a research project being conducted by (name), a (faculty
member, staff member, graduate student, undergraduate student) in the Department of (name) at
the University of Maine. If the principal investigator is a student, also name the faculty sponsor
and his/her department. The purpose of the research is _______________________________.
You must be at least 18 years of age to participate. The age statement is not always required.
An example of when it is required is if the study involves the UMaine undergraduate student
population. If there is a chance that someone in the population you are studying could be under
18, include the statement.
What Will You Be Asked to Do?
If you decide to participate, you will be asked to take an anonymous survey. It should
take you about X minutes to complete.
Risks:
Note that there is always some risk, at minimum the participant’s time and inconvenience. Listed
below are examples.

OR

-

Except for your time and inconvenience, there are no risks to you from
participating in this study.

-

There is the possibility that you may become uncomfortable answering the
questions. You may skip any questions that make you uncomfortable. Provide
referral resources if questions very sensitive, e.g., depression, suicide, etc.
Referral resources may include UMaine Counseling Center (if UMaine students),
National Hotlines, etc. Either mention the resources within the consent, or link to
resource information (see referral handout)..

Benefits (Two benefit statements are required – benefit to participant (if any) and potential
benefit of the research)
(Most surveys do not have a benefit to participants)
-

While this study will have no direct benefit to you, this research may help us learn
more about…

Compensation: Listed below are examples; if you are not offering compensation, leave this
section out. NOTE: See Item #7 on checklist for additional guidance if
compensation exceeds $75.

-

You will receive $X for participating in this study.
You may enter a raffle to win one of two $25 Amazon gift cards.
You will receive 1 hour of research credit (or other wording for extra credit) for
participating in this study.

Confidentiality
This study is anonymous. Please do not write your name on the survey. There will be no
records linking you to the data. Data will be kept on a password-protected computer indefinitely.
Information for the raffle/compensation/extra credit is not connected to survey responses.
Voluntary
Participation is voluntary. If you choose to take part in this study, you may stop at any
time. Explain whether stopping will alter compensation to be received, e.g., “… stop at any
time, but you must reach the end of the survey to enter the raffle; “While you may skip the
occasional question, you must complete the survey to be eligible for compensation.” You may
skip any questions you do not wish to answer.
Submission of the survey implies consent to participate.
Contact Information
If you have any questions about this study, please contact me at (phone, e-mail). You
may also reach the faculty advisor on this study at (phone, e-mail). If you have any questions
about your rights as a research participant, please contact the Office of Research Compliance,
University of Maine, 207-581-2657 (or e-mail umric@maine.edu).

SAMPLE CONSENT FORM
(Use in conjunction with the checklist!)
You are invited to participate in a research project being conducted by (name), a
(faculty member, staff member, graduate student, undergraduate student) in the Department
of (name) at the University of Maine. If the principal investigator is a student, also name
the faculty sponsor and his/her department. The purpose of the research is
_______________________________. You must be at least 18 years of age to participate.
The age statement is not always required. An example of when it is required is if the study
involves the UMaine undergraduate student population. If there is a chance that someone
in the population you are studying could be under 18, include the statement. There may
need to other inclusion criteria listed, such as “You must be between 50-75 and have
suffered a stroke in the last two years.”
What Will You Be Asked to Do?
If you decide to participate, you will be asked to (describe procedures, give
examples of sample questions if applicable). If the study involves a focus group, indicate
how many people will be in the group. If an interview or focus group will be recorded, state
that in this section. It may take approximately (amount of time) to participate. If the
procedures are numerous, we suggest you use bullets to make the form easier to read.
Risks:
Note that there is always some risk, at minimum the participant’s time and inconvenience.
Listed below are examples.

OR

-

Except for your time and inconvenience, there are no risks to you from
participating in this study.

-

There is the possibility that you may become uncomfortable answering the
questions. You may skip any questions that make you uncomfortable.
Provide referral resources if questions very sensitive, e.g., depression,
suicide, etc. Referral resources may include UMaine Counseling Center (if
UMaine students), National Hotlines, etc. Either mention the resources
within the consent, or reference an attachment with resource information.

Benefits (Two benefit statements are required – benefit to participant (if any) and potential
benefit of the research)
-

While this study will have no direct benefit to you, this research may help us
learn more about…
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-

You may learn how your energy level changes your mood. In addition, this
research may help us learn more about…

-

You will have a cholesterol screening at no charge. In addition, this research
may help us learn more about…

Compensation: Listed below are examples; if you are not offering compensation, leave this
section out. NOTE: See Item #7 on checklist for additional guidance if
compensation exceeds $75.
-

You will receive $X for participating in this study.
You will receive $X for completing the first part of this study and $X for the
remaining part.
You will receive 1 hour of research credit for participating in this study.
You will be able to enter a raffle for a $X gift card to ______.

Confidentiality
Sample for when data are confidential, i.e., names are connected to data, typically by use of
a code/key. NOTE: this is a sample; it may not fit your study. The important aspect is to tell
people how the data will be kept to ensure confidentiality and how long it will be kept – or
to inform that that it won’t be kept confidential, as in the case with some studies (e.g., oral
histories).
Your name will not be on any of the data. A code number will be used to protect
your identity. A key linking your name to the data will be kept separate from the data in a
locked office (if paper) and destroyed by XXXX (date). If a key will be kept electronically,
explain that it will be stored on a password-protected computer using software that
provides additional security. Data will be kept on a password protected computer and kept
(indefinitely or destroyed by date). Specifically address the retention of any audio, video, or
film recordings. List others who may have access to data, such as faculty advisor and/or
others working on the project. If a transcription service will be used (instead of named
researchers), include that information. Your name or other identifying information will not
be reported in any publications (statement not needed for anonymous studies).
For Focus Groups, also include this statement: Due to the group format, I cannot guarantee
that others will keep responses confidential.
Voluntary
Participation is voluntary. If you choose to take part in this study, you may stop at
any time (explain whether stopping will alter the benefit or compensation to be received).
You may skip any questions you do not wish to answer.
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Contact Information
If you have any questions about this study, please contact me at (phone, e-mail).
You may also reach the faculty advisor on this study at (phone, e-mail). If you have any
questions about your rights as a research participant, please contact the Office of Research
Compliance, University of Maine, 207-581-2657 (or e-mail umric@maine.edu).
If the study is not exempt from further review, continue with the following statement.
Your signature below indicates that you have read the above information and agree
to participate. You will receive a copy of this form.
_____________________________________
Signature

________________
Date

NOTE: If your study involves children (<18 years old), the consent letter is written to Dear
Parent/Guardian, and reference to “your child” or “your son/daughter” is used.

EMAIL RECRUITMENT TEMPLATE ELECTRONIC SURVEY
Greetings,
You are invited to participate in a research study. The research is being conducted by (name,
title, Department at the University of Maine). Say how the participant’s contact information was
obtained for example: John Doe suggested I contact you or I found your contact information on
“Z” website. NOT needed if posting an email on listserve, Facebook, etc.). State the purpose of
the research. Insert age requirement, for example: you must be at least 18 years old to participate
(not needed if you know your targeted population is at least 18) or you must be between ages
____ to participate. Include any other applicable inclusion/exclusion criteria.
If you agree to participate, you will be asked to take an anonymous/confidential (state one or the
other!) survey. The survey will take approximately (state how much time it will take). If there is
compensation you should add that information in the recruitment email.
Please click on the link below to learn more about the study and to take the survey (insert survey
link – FYI the first page of the survey will be the consent form).
If you have any questions, please feel free to contact me at (insert email and phone number).

General Email Posting (listserves, Facebook, University folders, etc.):
You are invited to participate in a research study. The research is being conducted by (name,
title, Department at the University of Maine). Insert age requirement for example: you must be
at least 18 years old to participate (not needed if you know your targeted population is at least
18) or you must be between ages ____ to participate. Include any other applicable
inclusion/exclusion criteria.
I am conducting a research study about (insert purpose of research). If you agree, you will be
asked to (briefly describe procedures, including time commitment, location, any recording –
audio/video).
If you would be interested in participating in this study, please contact me (provide contact
information).
Thank you.

Phone Script (interview over the phone/in-person):
Hello, my name is (name) and I am a researcher at the University of Maine. Say how
participant’s phone number was obtained. I am conducting a research study about (insert
purpose of research). I am calling to ask if you would be willing to let me interview you. The
interview can be conducted over the phone or at a location of your choosing. The interview
should take (insert time interview will take). Say if the interview will be recorded. Insert age
requirement, for example: you must be at least 18 years old to participate (not needed if you
know your targeted population is at least 18) or you must be between ages ____ to participate.
List any other applicable inclusion/exclusion criteria.
If you would be interested in participating in this interview, we can set up a time now or you can
let me know when a good time would be to schedule it.
If interested, investigator will set up date and time and will provide participant with investigator
contact information. For example: I have scheduled you for an interview on (date and time). If
you have any questions, I can be reached at (insert phone number and email). Thank you for
your help.
If participant is not interested, investigator will end the call. Thank you for your time.

Email/letter recruitment:
My name is (name) and am a researcher at the University of Maine. Say how participant’s
contact information was obtained.) I am conducting a research study about (insert purpose of
research).
I am contacting you to ask if you would be willing to participate. Participation would involve
(briefly explain what they will be asked to do and where it takes place). Insert age requirement
for example: you must be at least 18 years old to participate (not needed if you know your
targeted population is at least 18) or you must be between ages ____ to participate. List any
other applicable inclusion/exclusion criteria.
If you would be interested in participating, please reply to this email/contact me (provide contact
information).
Thank you for your time.

INVITATION TO PARTICIPATE
IN A UNIVERSITY OF MAINE
RESEARCH STUDY

You are invited to participate in a research study about (add
research topic).
Give name of PI(s), Title, and Department at the University of Maine.
We are looking for individuals (add age requirement here) who would want to participate in an
(recorded, if applicable) interview. If in person, give a location or say over the phone. The
interview may last between (give time it will take). If there is compensation and/or
refreshments it should be listed in the announcement.
All information shared in the interviews will remain confidential.

If you would like to participate and/or have questions about
this study, please contact (add name, phone and email).

SAMPLE SONA RECRUITMENT SCRIPT
Study Name: Recruitment Messages and Course Selection
Type: Online
Credits: 1 credit
Description:
We are working to understand how college admissions view books are related to the desire to
take courses or participate in a certain major. You will be randomly assigned to view either
captions or photos from a certain major. We will ask you a series of
questions concerning your beliefs, interests, and other personal factors. You must be 18 years of
age or older to participate in this research survey.

Human Subjects

Deadlines fo r Submission of Applications for Approval
IRB Overview
For submission of applications, the Protection of Human Subj ects Review Board (IRS) has

Guidance & Policy
Regulations

a standard deadline date of the first Friday of every month. An application submitted o n
the fi rst Friday of the month will be reviewed at that month's meet ing (the IRB typica lly
meets during the 3rd week of the month).

Training
An investigator may requ est an expedited review of his/ her application if the proposed

Forms and Samples
Application Deadlines

research activity is w ithin one of the categories eligible for expedited r eview. Applications
requesting expedited review may be submitted at any time. The IRB aims to review and
send comments back to investigators w ithin ten working days.

Resources
Please contact the IRB office if you have questions.

!RB FAQs
Institutional Review Board MembershiP- list

Human Subjects

Resources
IRB Overview
• Deadlines: The deadline for submitting applications for approval is the first Friday of

Guidance & Policy

the month.
• IRB MembershiP- Ust

Regulations

• What is HIPAA?

Training

Useful Links

Forms and Samples

• Considerations and Recomme ndations Concerning Internet Resea rch and Human

Application Deadlines

Subj ects Research Regulations (PDF)

Resources

• Federal and State Regulations & Guidance Materials

!RB FAQs

• Hum an Subj ect Regulations Decision Charts
• Public ResP-onsibili!.Y. in Medicine and Research (PRIM&R}. (Mission: Since its
founding in 1974, Public Responsibility in Medicine and Research (PRIM&R) has been
comm itted to the adva ncem ent of strong research programs and to the consistent
application of ethical pr ecepts in bot h medicine and research. Through national
conferences and published reports ther eon, it has addressed a broad range of
issues in biom edical and behavioral research, cl inical practice, ethics, an d the law.

f
Apply

Student Resources
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Nond 1scnm1nauon notice

Clery Safety and Secunty Report

Uruve1 s1ty of Mame
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COV!0 - 19 health and .safety guidance

Emergency

Human Subjects
IRB FAQs
IRB Overview
Guidance & Policy
Regulations
Training

Definitions:
Q. What is the IRB?
IRB is the acronym for the Institutional Review Board for t he Protection of Human
Subjects. The IRB reviews all research conducted by facu lty, staff and st udents that

Forms and Samples
Application Deadlines

involves human subj ects. The purpose of the IRB is to ensure that research with human
subjects is cond ucted ethica lly. The IRB ensures th at the risks to participants are
minimized, that selection of participants is equitable and that participants are informed

Resources

about what participation in the study w ill entail.

!RB FAQs

Q. What is considered research by the IRB?
A systematic investigation, inclu ding research development, testing and evaluation,
designed to develop or cont ribute to generalizable knowledge.

Q. What is the differ ence between consent an d assent?
Consent: Can only be give n by a compet ent individ ual who is of legal age and has been
give n sufficient information abou t the purpose of the study, t he benefits and risks of the
study.
Assent: Agreement of a minor to participate in a research study. Assent MUST be
accompanied by informed consent of the minor's parent or legal guardian.

Q. What is the d iffer ence between compensation and benefits?
Compensation: Is a payment o r reimbursement of the participant's time or expense. This
can even be class credit.

Benefits: Is something that can be related to or resulting from r esearch efforts. Could be a
benefit to the subject or to society.
Q. What is the d iffer ence between an ony mous and confi dential data?
Anonymous means that yo u are not collecting any identifying data from the subjects and
that you will have no means to contact or follow-u p w ith the subj ects.
When data is confidential, identifiable data will be co llected and the researcher can
identify the subj ect. In this case the subject could b e contacted fo r follow-up procedures.

COVID and IRB Applications:
Q. Where can I find information ab out research an d current COVID restrictions?
See official information about the University'. of Maine P-Olicies on restrictions on research.
Q. What modifications should I make to my applicat ion?
The researcher should first review the University'. of Maine COVID-19 guidance for
researchers. You sh ould modify any in-person researc h visit that does not have to be
con ducted on-site to a remote visit. These changes will r equire a modifi cation submission.
Q. Are there COVID changes that do not require a modification?
The IRB has determined that these activities are not considered a 'change to the research'
and therefore do not need to be submitted as mod ifications to r esearch protocols:
• General communications with subjects about COVID-19. These are not study-specific
comm unications, but rather ar e providing in formation that is publicly available, e.g.,
on the Univer sity of Maine w ebsite or CDC recommendat ions.
• Screening pro cedures for COVID-19 infection consi stent with procedures on the
University: of Maine COVID-19 guidance for researchers. These are not study-speci fic
procedures.

Initial Submissions:
Q. What documents do I need to submit with my in it ial submission?
This w ill vary depending on your study but in genera l yo u will need to submit a cover
page and an application that inclu des the narrative, measures you w ill administer,
recruitment script(s), consent form(s) and assent script (fo r studies with participants
under 18 years old).
Initial submissions should be as complete as possible but we understand that
submissions ar en't perfect from the start (especially if it is yo ur first submission). Prepare
what you believe is needed, and the IRB Office will let you know of any changes or
additi onal documents that are needed fo r you r IRIB r eview.
Q. My stu dy is Quality Improvement; do I need to s ubmit an application?
If your project involves human subjects or their data, the best practice is to check with the
IRB to confirm if I RB oversight is r equired, even if you think your project is Quality
Improvement or Quality Assurance. You may simply provide a brief explanation of your
study al ong w ith some sample measures to umric@maine.edu and the I RB will let you
know if an application is requ ired.
Q. Which consent template should I use?

We have several consent form tem12lates on the IRB website to choose fro m. Select the
templat e yo u believe is appropriate, and the IRB Office will let you know if something
d ifferent is needed once they start their review.

Q. Does my project need IRB review?
The project must be research and involve human subj ects to need IRB review. Please do
not attempt to determine for yourself that your proj ect is not research involving human
subjects. Yo u should have the IRB m ake t his det ermination.
The Common Rule defines "research" as a systematic investigation, inclu ding research
development, testing and evaluation, designed to develop or contribute to generalizable

knowledge.
Systematic is an act ivity that follows a written plan and adheres to scientifically accepted
principles for research design to answer a question. Exam ples of some activities are
surveys, interviews, review of medica l charts.

Generalizable knowledge is defined as knowledge from w hich co nclu sions will be drawn
that can be applied to populations outside of the specific study population. The results
are expected to be generalized to a larger population beyond the site of data collection;
the results are intended to be replicated in other settings.
The Common Rule defines a human subject as a living individual about whom an
investigator conducting r esearch obtains (1) information or biospecimens throug h
intervention or interaction w ith the individual, and, uses, stud ies, or analyzes t he
information or biospecimens; or 45 CFR 46.102(e) (2) uses, studies, analyzes, or generates
identifiable private information or identifiable biospecimens.

Q. When should I submit my application?
If your study is exempt or can be expedited you should submit your application at least
30 days befo re you intend to start your research. This allows the IRB time to review it and
it will you give t ime to make any changes requested by the IRB in a timely manner and still
meet you start date. For Full Board review, yo ur proposal should be submitted by the
submission deadline listed on the IRB website.

Q. What should be my consideration if I am using Zo om for my study?
Yo u should create a private meeting with a unique meeting ID and password. To protect
the privacy of the participants, consider using only audio and not video recording. Learn
more about Zoom guidance for IRB studies.

Q. What information should be included in the recruitment materials?
The recruitment scripts must have sufficient information so potential participants can
make an informed decision about parti cipation. The following items must be inclu ded:
• The name and contact information of the Principal Investigator.
• The purpose of the res earch.
• The time commitment required of subjects.
• The location of the research.
• A cl ear statement that it is a r esearch proj ect.
• A clear statement that it is voluntary.

IRB Approvals:.
Q. My research w ill be done in another country. Do I need IRB approval from the

University of Maine?
Yes, you must get approval fro m the IRS at the Un iversity of Maine. Yo u should also be
aware that you many need approval from an IRB or ethics committee from the country
wh ere you w ill be conducting the study, so please plan accordingly.

Q. Do I need approval from the IRB even if my study if not funded?
Yes, you must obtain IRB approval from the University of Maine regard less of funding.

Q. May I begin recruitment of subjects while IRS approval is pending?
No, you need IRB approval BEFORE recruitment or study enrollment begins.

Q. Do I need to submit an IRB application if I am not collecting any identifying in formation
in my research proj ect?

Q. Can the IRB approve a resear ch study retroactiv ely?
No, there is not provision in the Federal regulations that allows the IRB to approve a study
that has already been conducted. This is why it is so important to check with the IRB if
approval is needed before you start a research st udy.

Q. What if I am not sure if my activity needs I RB rev iew?
Email a brief summary of the activity to umric@maine.edu and the IRS w ill respond with a
determination.

Q. If I submit a grant proposal do I have to submit an IRB application at the same time?
You can submit the IRB application at the same time as the proposal. Depending on the
sponsor you may also submit the IRB application at the time of award. We st rongly
encourage yo u to check w ith the sponsor on their requ irements.

Principal Investigator and Study Team Management:
Q. I am leavi ng the University; what happens to my IRB study?
The Pl should close out the applications or notify the Office of Research Compliance in
writing that the study w ill be t ransferred to another qualified Pl at the University of
Maine.
Changes in t he Pl should be submitted to the IRB p rior to the new Pl assuming oversight
of the study. The change must be submitted at least 14 business days prior to the
departure of the former Pl. If the former Pl is leaving the institution bu t will r emain a
study team member, please contact the IRB office. See "How do I submit a change in Pl?"
below.
If the study is funded the Pl should also notify the Office of Research Administration.

Q. How do I submit a change in Pl?
The cha nge in Pl should be submitted as a modification. The req uest will be reviewed at a
Full Board meeting unless the original study was expedited and continues to meet criteria
for review under expedited procedu res.
The research team should consider wh ether study documents are affected by the change
in Pl, such as the consent forms and recruitment materials. If participants ar e still
enrolled in the research study, the IRB r ecommends that the research team provides a
written update to the participants, such as an info rmation sheet or letter, to inform them
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(e.g., for study-related quest ions).

Q. What is the faculty sponsor's role for student projects?
The main expectation is that the sponsor assists st udents during the IRB process . The
sponsor must review t he application before submission to ensure that the application is
thorough and accu rate. The facu lty sponsor must also monitor the st udents during the
study to ensure t hat the student is following the procedures described in the application
and that if any unexpected or adverse events occur they are prom ptly r eported to the IRB.
If the Facu lty Sponsor is leaving the institution and the study is still active another
qualifi ed Faculty Sponsor must be appointed; see "How do I submit a change in Pl?"
above.

Q. How do I add stu dy personnel to my approved IRB study?
If you simply need to update personnel on an approved study, you do not need to edit
the approved application. An email to umric@ma ine.edu referencing the st udy title and
number along w ith name of person(s) to be added, years of human subj ect s research
experience, role on th e proj ect, and email is suffici ent. If the CITI train ing was not
completed through UMaine please also provide th e CITI t ra ining certifi cate.
Some personnel changes may also require a change to other sections of the application
such as the consent document, and r ecruit ment materials. In such cases, the application
should be modified to include these changes and submitted as a modification for review.

Q. Who should be listed as study staff on the applicat ion?
All study staff members w ho are reasonably engaged in t he design, conduct or analysis of
the study sh ould be listed in t he application. If the sta ff or st udents w ill have direct
contact with subjects or access to subject ident ifiable data, th ey must be listed in the

application. The person must also have completed all the re~uired IRB training.

Q. Do all per sonnel have to be listed on the consent form?
No. The Pl must be listed on the consent form . Beyond that, we suggest no m ore t han 3
people the research participant is most likely to en counter during the conduct of the
study.
Co-Investigators are not required to be listed on th e consent form.

Ongoing Study Management:
Q. How do I submit a continuing review?
You will need to submit the continuing r eview fo rm that was emailed t o you along with
the status report and consent forms to umric@maine.edu. If yo u ar e also requesting a
modification, you w ill also need t o submit the edited application and fo llow the
modifi cation instructions on the IRB webs ite. Do n ot wait until the Study Expiration date
to submit your continuing review, as the study will very likely enter lapse state.

Q. I did not submit my cont inuing my review and m y study has lapsed, what does this
mean?
The IRB Office sent you r eminders for a continuing review and you did not respond to the
IRB. Please submit the continuing r eview documents or study closure immediately.
Research act ivities must stop wh ile the study is lapsed. This includes recruitment,
consent, interactions w ith partici pants, and collect ion of data. Advertisements cu rrently

running in the m edia must be pulled. Data collected during a lapse in IRB approval cannot
be used. Continuation of research activities w ithout IRB approval is a violation of federa l
regu lations.

Q. When should I cl ose my IRB application?
When all research activities are com plete. We recommend you keep you r study open until
j ournal manuscripts have been submitted an d accepted, just in case further data analys is
is needed.

Q. Do I need to report to the IRB w hen a study is completed?
Yes, the regulat ions requ ire "prompt reporting to the IRB of changes in r esearch activity."
Completion of a study is a change in activity and sh ould be reported to the IRB.

Q. Can I rea ctivate a previously closed study?
Yes. See Reactivating a Closed Study for guidance.

Working with Outside IRBs:
Q. Will the University of Maine rely on a foreign IRB?
We w ill not r ely on an IRB that is outside of the United States.

Q. What is the d ifference between Single, Reviewing and Relying IRB?
Single IRB: One I RB of record (also called Reviewing I RB), selected on a study-by-study
basis, that provides the regulato ry and ethical review for all sites participating in a
multisite study.
Reviewing IRB: The IRB providing regulatory oversi ght (IRB of Record ) for any participating
sites that have waived oversight to this IRB.
Re lying IRB: The IRB of a participat ing site that has wa ived regu latory oversight to another
IRB (the Rev iewing IRB).

IRB Required Training:
Q. Federal r egulations req uire that all researchers receive ethics train ing. How do I meet
this requirement?
All staff, students and faculty who submit an application for IRB review must complete the
online CITI training.

Q. What if not all personnel have com pleted CITI training but I rea lly need to get started
on my r esearch?
That is okay. You can submit the application w ith just those people that have completed
the training and get approved to start you r research. Once additional personnel complete
the training, you ca n submit an email to umric@lmaine.edu requesting to add those
individuals, following the inst ructions to re~uest a modification to a P-reviously....s!P-P-roved
study.

Q. I comp leted the CITI Responsible Conduct in Research (RCR) course. Does thi s meet the
IRB training requirement?
No. All personnel must com plete the Social/Behavioral or Biomedica l IRB course. See
instructions for selecting the correct IRB training.

